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ABSTRACT OF THE DISSERTATION 
 
Associations Between Peripheral Immune Markers, Neural Response to Stress, and Depressive 
Symptoms During Adolescence: The Role of Daily Stressors, Affect, and Sleep Habits 
 
by 
 
Jessica Phuong Uy 
Doctor of Philosophy in Psychology 
University of California, Los Angeles, 2020 
Professor Adriana Galván, Chair 
 
Adolescence is characterized by marked development in neurobiological, 
neuroendocrine, and psychosocial domains that are posited to contribute to the increased onset 
and prevalence of depression and other psychiatric disorders. Emerging research also suggests an 
association between inflammation and affective symptoms in adolescents; however, the neural 
correlates that link immune functioning and affective symptoms in adolescents have been 
relatively understudied. The current dissertation utilized a multi-method approach (daily diary, 
fMRI, venipuncture samples) to investigate the role of inflammation in modulating neural 
function of stress/affective circuitry in a sample of adolescents (14-15 years). Results revealed 
that negative affect and poor sleep (short sleep duration and high sleep variability) moderated the 
associations between peripheral inflammatory markers and neural activation in stress-related 
circuitry. Specifically, among adolescents who reported high negative affect and short sleep 
 iii 
duration, greater levels of the pro-inflammatory tumor necrosis factor-alpha (TNF-a) were 
associated with heightened activation in frontolimbic regions (e.g., amygdala, medial prefrontal 
cortex [MPFC]) on an fMRI stressor task, which was associated with greater stress-related 
anxiety and negative appraisals. Among adolescents who exhibited high sleep variability, greater 
levels of interferon gamma (IFNg) were associated with lower activation in lateral PFC regions 
during stress, which was associated with poorer cognitive performance on the stress task. These 
immune-brain associations were attenuated among those who reported low negative affect, long 
sleep duration, and low sleep variability, suggesting that negative affect and poor sleep habits 
may sensitize the brain to peripheral immune signaling. When homeostasis is imbalanced (e.g., 
insufficient sleep), higher levels of TNF-a and IFNg may reflect a homeostatic drive to induce 
sickness-type behaviors/states (e.g., negative affect, increased anxiety, poorer cognition) to 
restore homeostasis (e.g., promote sleep) via modulation of respective neurocircuitry in 
adolescents. 
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Chapter 1. Introduction  
Adolescence is a unique developmental period of transition from childhood to adulthood 
during which significant physical maturation occurs. Alongside hormonally-driven physical 
transformations arise notable changes across psychosocial and cognitive domains (Crone & 
Dahl, 2012; Steinberg, 2008), brain structures and functions (Casey, Getz, & Galván, 2008; 
Galván et al., 2006; Giedd et al., 1999; Mills et al., 2016; Sowell et al., 2004), and 
neuroendocrine systems (Dahl & Gunnar, 2009; Romeo, 2017; Romeo et al., 2014). There is 
growing evidence that the immune system also undergoes important development during 
adolescence (Brenhouse & Schwarz, 2016). Yet, the relation between the immune system and 
brain development and behavior is not clearly understood. Emerging evidence from human adult 
and animal work implicate the immune system in psychological functioning and well-being. 
However, it is unclear whether psychoneuroimmunological models in animals and adults 
translate to adolescent samples. The robust plasticity across these systems during adolescence 
presents a period of both opportunity for enrichment as well as increased vulnerability. Indeed, a 
number of psychiatric disorders manifest during adolescence and early adulthood 
disproportionately more often compared to other developmental stage in the lifespan (Mojtabai, 
Olfson, & Han, 2016; Substance Abuse and Mental Health Services Administration, 2017). 
Understanding the interplay between physical and psychological well-being will provide novel 
perspectives on elucidating the mechanisms of adolescent depression for interventions. 
Stress and depressive symptoms 
 There is a strong association between stress and depressive symptoms across the lifespan 
(Dean & Keshavan, 2017; Hammen, 2015; Pizzagalli, 2014). Proposed mechanisms that explain 
this association include dysfunctions in HPA axis function and cortico-limbic circuitry involved 
 2 
in emotion regulation – particularly characterized by heightened responses to negative events and 
blunted reactivity to positive events. Indeed, stressful experiences in early life may sensitize 
cortico-amygdala circuitry to threat, which could potentiate the neuroimmune systems and 
perpetuate the cycle of vulnerability (Nusslock & Miller, 2016). Regional variation in 
developmental timing of the cortico-limbic circuitry – that is, greater engagement of limbic 
systems relative to prefrontal systems and the increasing engagement of prefrontal regulation of 
limbic systems during adolescence – is a proposed mechanism by which stress in early life 
increases risk for poorer physical and mental health in adolescence and adulthood. However, 
depressive symptoms still emerge in adolescents without a history of early adversity, suggesting 
that stress need not be traumatic or occur early in life to alter the links between cortico-limbic 
circuitry and depressive symptoms in otherwise healthy adolescents. 
Inflammation and depressive symptoms in adolescents 
There is an extensive body of literature demonstrating a link between psychological well-
being and immunity in adult human and animal work. The comorbidity of major depressive 
disorder and physical illness and the similarities between depressive symptoms and sickness 
behavior (e.g., fever, decreased appetite, cognitive dysfunction) have enhanced our 
understanding and recognition of the bidirectional effects of inflammation and depression 
(Dantzer, 2001; Hart, 1988; Kelley et al., 2003; Quan & Banks, 2007).  
Studies that have examined the associations between immune markers and depression in 
adolescents have typically focused on group differences in immune markers between individuals 
with a diagnosis of major depressive disorder (MDD) and/or those who experienced early life 
stress or adversity (Miller & Cole, 2012). The few studies that have investigated these 
associations in typically developing youth either only reported data from females who were at 
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high-risk for depression (Miller & Cole, 2012) or youth under 13 years of age (Caserta, Wyman, 
Wang, Moynihan, & O’Connor, 2011; Keller, El-Sheikh, Vaughn, & Granger, 2010), which does 
not reflect the span and variability of adolescence. Moreover, differences in how immune 
markers were acquired and assayed – through saliva (Keller et al., 2010) and dried blood spots 
(DBS) (Guan et al., 2016) – make it challenging to compare findings across studies. Recent 
studies examining depressive symptoms and immune processes during adolescence have found 
that greater levels of depressive symptoms were associated with greater stress-related increases 
in circulating inflammatory markers among adolescents with greater adiposity (Chiang, Bower, 
Irwin, Taylor, & Fuligni, 2017), higher levels of CRP among those with low parental support 
(Guan et al., 2016), and upregulated expression of inflammation-related genes and 
downregulated expression of antiviral-related genes (Chiang et al., 2019b). These studies 
demonstrate that associations between depressive symptoms and immunity can be detected 
during adolescence and in otherwise healthy adolescents. What is not well elucidated are the 
neural mechanisms that may mediate the link between inflammation and affective symptoms 
during adolescence. 
Stress and the immune system 
Overview of the immune system 
The purpose of the immune system is to recognize and defend the organism against 
invasion from viruses, bacteria, and other antigens. As part of the immune response, immune 
cells secrete elevated levels of immune molecules, including cytokines and chemokines, which 
promote an inflammatory response that coordinates a cellular attack against pathogens 
(Medzhitov, 2008). The immune system is comprised of two interconnected branches: innate 
immunity and adaptive or acquired immunity. The innate immune response allows a rapid, 
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robust immune response to a pathogen through highly conserved mechanisms without requiring 
that the organism has previous exposure to the pathogen. Upon detection of a pathogen, 
regulatory transcription factors (e.g., nuclear factor-kB [NF-kB] and interferon [IFN]) are 
activated and drive the expression of pro-inflammatory genes (e.g., interleukin-1 [IL-1] and 
tumor necrosis factor-a [TNF-a]) that produce cytokines, the main contributors of the 
inflammatory response. Inflammation is a response by which the innate immune cells induce 
cytokines and chemokines to eradicate pathogens and promote tissue healing. These cytokines 
are classified as either pro-inflammatory (stimulate immune response; e.g., IL-1b, IL-6, or TNF-
a) or anti-inflammatory (attenuate immune response; e.g., IL-10). If a pathogen survives or 
evades the action of the innate immune response, the adaptive/acquired immune response 
becomes activated. In contrast to the non-specific response of innate immunity, 
adaptive/acquired immunity involves proliferation of memory-based (i.e., previous exposure to 
specific pathogen) microbial-specific white blood cells (lymphocytes, such as helper T cells, 
cytotoxic T cells, and B cells) to eliminate microbes. In response to a cellular pathogen (e.g., 
virus), a subset of T-helper lymphocytes (Th1 cells) produce cytokines, including IFNg, to 
promote inflammation and activate macrophages and antigen-specific cytotoxic T cells to lyse 
the infected cells. Both pro- and anti- inflammatory responses are necessary for proper immune 
function. Dysregulation of the inflammatory response could lead to low-grade, chronic 
inflammation, which has implications for the pathogenesis of certain psychiatric and physical 
illnesses. 
The immune system matures and changes throughout the lifespan, thereby differentially 
impacting the brain and behavior (Ellis, Mouihate, & Pittman, 2005; Levy, 2007; Ortega, Jadeja, 
& Zhou, 2011). For example, rats that have been challenged neonatally with lipopolysaccharide 
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(LPS) toxin show suppressed febrile responses, amplified HPA response as adults compared to 
those who received saline neonatally (Ellis et al., 2005), and increased mRNA expression levels 
of cytokines in the brain in adulthood (Ortega et al., 2011). Additionally, cytokine secretion of 
newborn cells is characterized by decreased IFN, decreased production of TNF-a and IL-1b, and 
decreased IL-10 (Kollmann, Levy, Montgomery, & Goriely, 2012; Lee et al., 2008). In contrast, 
older adults evince elevated levels of proinflammatory cytokines and increased 
immunosenescence (Kollmann et al., 2012). Compared to the known changes in the immune 
response at the extreme ends of development, less is known about normative changes in the 
immune system from childhood to young adulthood, and how these changes may modulate stress 
sensitivity in the neuroimmune system.  
Immune response to stress 
When confronted with a physical or psychological stressor, a cascade of events occurs to 
prepare the organism to respond to the stressor, including release of neurotransmitters (e.g., 
epinephrine and norepinephrine) via the sympathetic nervous system (SNS) and release of 
hormones along the hypothalamic-pituitary-adrenal (HPA) axis. The rapid SNS response 
increases gene expression of pro-inflammatory cytokines, presumably to prepare for pathogen 
removal and wound healing as a result of fight-or-flight (Irwin & Cole, 2011). The slower 
glucocorticoid response, on the other hand, initially reinforces SNS-mediated pro-inflammatory 
response, and then releases anti-inflammatory cytokines to attenuate the stress response. These 
molecules bind to stress-sensitive receptors throughout the brain (or activate immune cells in the 
brain in the case of cytokines) to direct adaptive physiological and behavioral responses to 
overcome challenge. Impaired HPA axis function, as is common in situations of chronic stress 
and stress-related disorders, has consequences for the regulation and effectiveness of the immune 
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system. For example, a blunted HPA axis response may promote inflammation while excess 
circulating glucocorticoids may suppress immune function and increase susceptibility to 
infections (Sternberg, 2006). Therefore, a delicate balance of glucocorticoids is necessary to 
maintain homeostasis of the immune system. That these systems are undergoing considerable 
changes during adolescence makes it imperative to take a systems approach and utilize multiple 
methods across levels of analyses to better characterize adolescent development.  
Immune system and the brain 
In addition to neural regulation of the immune system, evidence suggests that the immune 
system also shapes the brain and behavior. Research shows that peripheral immune mediators 
(including IL-6 and TNF-a) can be transported across the blood brain barrier (BBB) to activate 
astrocytes and microglia (the macrophages of the brain), which make more cytokines in the 
brain. Cytokines could also signal the brain indirectly through the vagus nerve (Watkins, Maier, 
& Goehler, 1995). These signals act on relevant brain regions to modify feeding and sleeping 
behaviors, cognition, and social interactions, inducing generalized “sickness behaviors” (Banks, 
2015; Vitkovic et al., 2000). These behavioral responses to immune activation are conserved 
across many species and are the mechanism by which our bodies coordinate the brain and 
behavior during sickness to promote rest and recovery from infection. Hence, neurons are 
sensitive to the inflammatory signals produced in the periphery and in the brain (Brenhouse & 
Schwarz, 2016). In rodents, repeated stress increased circulating cytokines and brain 
macrophages in the parenchyma of the PFC, amygdala, and hippocampus, which explained 
increases in anxiety behaviors (Wohleb, Powell, Godbout, & Sheridan, 2013). Chronic exposure 
to glucocorticoids in rats also primed hippocampal microglia to pro-inflammatory stimuli and 
potentiated the microglial pro-inflammatory response (Frank, Hershman, Weber, Watkins, & 
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Maier, 2014), suggesting heightened sensitivity of the brain to threat. In humans, peripheral IL-6 
was inversely associated with gray matter volume of the hippocampus and medial PFC in 
middle-aged adults (Marsland, Gianaros, Abramowitch, Manuck, & Hariri, 2008), demonstrating 
that the hippocampus and PFC are targets of inflammation. The increased neuroplasticity during 
adolescence might present an opportunity for intervention to reverse the negative effects of 
stress. For example, rats that were exposed to early life stress via maternal separation as pups and 
then exposed to enriched environments during adolescence showed reduced cognitive deficits 
that was mediated by reductions in pro-inflammatory cytokine TNF-a relative to control (do 
Prado et al., 2016), demonstrating that the neural and cognitive effects of stress is amenable to 
interventions during adolescence. 
Inflammation and the adolescent brain 
There are very few studies that have examined the associations between peripheral 
immune markers and brain structure or function in adolescents. Research in adults has found that 
endotoxin administration, which elicits an inflammatory response, was associated with 
heightened neural reactivity to negative social experiences in socioemotional and pain regions 
compared to placebo, particular in the dorsal anterior cingulate cortex (dACC), anterior insula, 
and amygdala (Eisenberger, Inagaki, Rameson, Mashal, & Irwin, 2009; Eisenberger, Moieni, 
Inagaki, Muscatell, & Irwin, 2017; Inagaki, Muscatell, Irwin, Cole, & Eisenberger, 2012; 
Muscatell et al., 2016). Moreover, those who showed greater increases in pro-inflammatory 
cytokines in response to the inflammatory challenge showed greater activity in the dACC and 
anterior insula in response to social exclusion (Eisenberger et al., 2009). These studies suggest 
that inflammation might sensitize the brain to negative social experiences, including the social 
evaluative aspect of stress, which has implications for stress-related psychiatric disorders (e.g., 
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depression). Therefore, it is possible that adolescents who exhibit higher levels of peripheral pro-
inflammatory markers may show greater neural sensitivity to stress. One study that examined the 
associations between peripheral inflammatory markers and resting-state functional connectivity 
in African American adults (25 years) and adolescents (13-14 years) found that higher levels of 
inflammation were associated with lower resting-state functional connectivity in the emotion 
regulation network in adults and adolescents, with adolescents additionally showing a negative 
association with the central executive network (Nusslock et al., 2019). These findings suggest 
that the prefrontal cortex and regulatory processes may also be targets of inflammation during 
adolescence. 
Adolescents’ daily affective experiences, sleep habits, and inflammation 
Adolescents report experiencing more stress and show heightened and protracted HPA 
activity in response to stress (Dahl & Gunnar, 2009; Romeo, 2010; Romeo et al., 2014; Stroud et 
al., 2009), which has implications for prolonging the effects of stress on brain and immune 
function. Indeed, adolescents who reported having more negative social interactions with friends 
and family members showed higher levels of CRP (Fuligni, Telzer, Bower, Cole, & Irwin, 2009) 
and upregulation of inflammation-related genes (Chiang et al., 2019a). Whether daily stress and 
negative affect alter how the adolescent brain responds to stress, and whether inflammatory 
markers play a role in sensitizing regions implicated in stress responding, remains unexplored. 
Sleep also suffers during adolescence (Carskadon, Vieira, & Acebo, 1993; CDC, 2011; 
Kann et al., 2014). Using a wide array of sleep manipulations or observations (e.g., experimental 
partial or total sleep deprivation, naturalistic sleep disturbance, poor sleep efficiency), research 
shows that poor sleep is associated with increases in inflammatory markers such as CRP, IL-6, 
and TNF-a (Irwin, 2015; Irwin, Olmstead, & Carroll, 2016). Research examining how 
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adolescents’ sleep habits relate to inflammation have found that shorter sleep duration was 
associated with higher levels of CRP among young adolescents and that greater variability in 
sleep duration was associated with higher levels of CRP (Park et al., 2016). Shorter sleep 
duration was also associated with upregulation of inflammation-related genes and 
downregulation of antiviral-related genes (Chiang et al., 2019a). Research in adults has shown 
that poor sleep and acute stress act on similar neural and physiological systems (C. Anderson & 
Platten, 2011; Balbo, Leproult, & Van Cauter, 2010; Minkel et al., 2014; Spiegel, Leproult, & 
Van Cauter, 1999; Vgontzas et al., 2004; Yoo, Gujar, Hu, Jolesz, & Walker, 2007). Surprisingly, 
very few studies have examined these processes together in adolescents. In addition to 
demonstrating independent associations between daily stress and sleep on inflammation-related 
gene expression, Chiang et al. (2019a) also found that the association between daily stress and 
inflammation-related gene expression was exacerbated in the context of shorter sleep duration, 
suggesting that daily stress and poor sleep, both separately and together, shape inflammatory 
processes during adolescence. These findings suggest that one way by which insufficient sleep 
might contribute to increased inflammation may be through sensitizing the brain to stress, which 
would amplify the body’s inflammatory state and compound the immune system’s effects on the 
brain.  
What has yet to be investigated are the neural correlates that link daily emotional 
experiences and sleep habits to inflammatory processes. There is a need to fill this gap in the 
literature considering growing evidence of heightened response sensitivity to stress and that the 
brain regions most sensitive to stress (e.g., hippocampus, PFC, amygdala) continue to develop 
during adolescence (Giedd et al., 1999; Giedd & Rapoport, 2010; Lupien, McEwen, Gunnar, & 
Heim, 2009; Sowell et al., 2004) and are also targets of poor sleep (Dutil et al., 2018). Animal 
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research suggests that experience of daily stressors during adolescence (even in the absence of 
early life stress exposure) has the potential to affect behavior and brain development in limbic 
and cortical regions (Eiland, Ramroop, Hill, Manley, & McEwen, 2012; Isgor, Kabbaj, Akil, & 
Watson, 2004; McCormick & Green, 2013; McCormick, Nixon, Thomas, Lowie, & Dyck, 
2010), which may increase psychological and biological sensitivity to subsequent stress and 
contribute to low-grade chronic inflammation, which in turn would continue this positive 
feedback loop and increase risk for poor health outcomes.  
Overview of studies 
The overarching goal of my dissertation was to investigate whether and how 
inflammation (as a proxy for exposure to stress) modulated neural function of stress circuitry 
during adolescence, with implications for understanding how these processes relate to mental 
health and well-being. Specifically, I investigated whether and how individual differences in 
peripheral immune markers related to neural response to stress in adolescents (Study 1), and 
whether these immune-brain associations could be predicted by or moderated by adolescents’ 
daily experiences of stressors (Study 2) and sleep habits (Study 3). 
The proposed studies employed self-reported measures of adolescents’ depressive 
symptoms and daily experiences, a multiplex assay of immune cytokines obtained via 
venipuncture, and a functional magnetic resonance imaging (fMRI)-adapted laboratory stressor 
to investigate how the adolescent brain experiences acute stress. 
Study 1 examined the associations between peripheral immune markers, neural response 
to stress, and depressive symptoms in healthy adolescents (14-15 years). Most studies of stress 
during childhood and adolescence have been limited to examining the SNS and HPA stress 
systems. My dissertation focused on immune markers because of the emergent significance of 
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the immune system in neurodevelopment and mental health in addition to the general scarcity of 
neuroscientific studies related to immune markers in humans. The current study used 
venipuncture draws to assess plasma levels of immune markers, which has been the method by 
which a majority of studies collect immune information in humans. The current study also used a 
multiplex immunoassay, which provided information on the concentrations of multiple cytokines 
– pro- and anti-inflammatory – to inform better speculation of the mechanisms involved. The use 
of the multiplex immunoassay extends from current studies that primarily report on pro-
inflammatory cytokines IL-6 and C-reactive protein (CRP). To assess depressive symptoms, I 
utilized adolescents’ self-report of depressive symptoms on the Center for Epidemiological 
Studies Depression (CES-D) Scale. To assess neural response to stress, I used a modified version 
of the Montreal Imaging Stress Task (MIST) paradigm (Dedovic et al., 2005), an fMRI-adapted 
lab stressor. On the MIST, participants perform arithmetic problems under a non-evaluative 
“practice” condition and under a challenging and evaluative “test” condition, which contains 
both performance and social evaluative aspects of a robust stressor (Dickerson & Kemeny, 
2004). Previous research on the MIST has found an increase in salivary cortisol levels in the 
stress relative to control condition (Dedovic et al., 2005) as well as greater activation in stress-
related circuitry (e.g., cingulate, thalamus, insula, lateral and medial aspects of prefrontal cortex) 
in adults (Dedovic et al., 2005; Ming et al., 2017) and adolescents (Strang, Pruessner, & Pollak, 
2011). Moreover, greater activation in ventromedial and dorsolateral PFC regions in response to 
challenge was associated with smaller increases in salivary cortisol and lower depression scores 
in adults (Ming et al., 2017), implicating the role of the PFC in stress regulation. The current 
study extends from previous research to assess the role of peripheral immune markers in stress-
related circuitry during adolescence. 
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Study 2 investigated how adolescents’ experiences of daily stressors, daily negative 
affect, and stressor reactivity (i.e., affective responses to daily stressors) related to peripheral 
immune markers and neural response to stress. Participants were asked, each night for 7 days, to 
indicate on a checklist whether they experienced stressful demands from various sources and 
arguments with various people in their lives. Participants also rated how stressful they perceived 
the stressors to be, if any were indicated, and reported on their current experience of positive and 
negative affect. I investigated whether adolescents who 1) reported more stressors, 2) 
experienced greater negative affect, and/or 3) showed greater stressor reactivity (i.e., stronger 
correlation between number of daily stressors and negative affect) exhibited greater levels of 
peripheral inflammation and/or heightened neural response to stress, and explored mediating and 
moderating effects of these variables. The use of daily diary in this study captures variability in 
adolescents’ daily experiences and allows investigation of how the type of experiences and 
variability in those experiences in daily life relate to immune and neural outcomes.  
Study 3 investigated how adolescents’ average sleep duration and variability in sleep 
duration across the week related to peripheral immune markers and neural response to stress. 
Adolescents reported daily sleep duration for 7 days prior to coming into the lab for a blood draw 
and performing the fMRI stressor task in the scanner. I examined how adolescents’ sleep habits 
related to functional activation when performing the fMRI stressor task and explored whether 
inflammation was a mediating factor of sleep-related differences in stress response (if any) in 
adolescents and/or whether adolescents sleep habits moderated the association between 
inflammation and neural response to stress.  
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Chapter 2. Corticolimbic circuitry activation during stress relates to stress-related 
performance and anxiety in adolescents  
There is a significant increase in the onset and prevalence of depression during 
adolescence (Mojtabai et al., 2016; Substance Abuse and Mental Health Services Administration, 
2017). Notable changes in brain structure and function and neuroendocrine systems during 
adolescence have been posited to underlie the onset of depression. Recent evidence from human 
adult and animal work also implicate the immune system in psychological functioning and well-
being. However, the associations between the immune system, brain function, and behavior 
during development are not clearly understood. Understanding the interplay between physical 
and psychological well-being will provide novel perspectives on elucidating the mechanisms of 
adolescent depression for interventions. 
 There is a strong association between stress and depressive symptoms (Elovainio et al., 
2012; McLaughlin et al., 2012; Miller & Cole, 2012). Stress is also highly correlated with 
physical illnesses such as metabolic syndrome, coronary heart disease, and certain cancers 
(Braveman, Cubbin, Egerter, Williams, & Pamuk, 2010; Danese & McEwen, 2012; Danese & 
Tan, 2014). Indeed, many people who have depression are likely to have concomitant physical 
illnesses (R. J. Anderson, Freedland, & Lustman, 2001; Carney et al., 1988; McDaniel, 
Musselman, Porter, Reed, & Nemeroff, 1995). Inflammatory processes have been hypothesized 
to be a key mechanism explaining the links between, stress, depressive symptoms, and physical 
illnesses (Hiles, Baker, de Malmanche, & Attia, 2012; Mitchell & Goldstein, 2014; Slavich & 
Irwin, 2014). Because immune processes interact with endocrine processes that are in flux during 
adolescence, understanding the role of the immune system during this sensitive period of 
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development has implications for reducing the risk of stress-related psychological and physical 
illnesses in adulthood. 
Research demonstrates that inflammatory markers are elevated in adolescents with major 
depressive disorder (MDD) compared to healthy controls (Gabbay et al., 2009; Henje Blom et 
al., 2012), which was positively correlated with self-reported anxiety and depressive symptoms 
(Henje Blom et al., 2012). Post-mortem samples of adolescents who completed suicide showed 
greater mRNA and protein expression levels of IL-1b and TNF-a in PFC compared to controls 
(Pandey et al., 2012). Moreover, within individuals, higher levels of inflammation (IL-6 and 
CRP) were present during major depressive episodes relative to euthymic periods, with elevated 
CRP persisting over 6 months and elevated IL-6 predicting future major depressive episode 
(Miller & Cole, 2012). 
In the few studies that have examined inflammatory markers in healthy youth without 
clinical depression, greater levels of salivary IL-6 were associated with adjustments problems in 
children (mean age = 9.85 years) (Keller et al., 2010) whereas higher perceived self-efficacy was 
associated with lower plasma IL-6 concentrations in 7-13 year-olds (Caserta et al., 2011). Recent 
studies examining depressive symptoms and immune processes during adolescence have found 
that greater levels of depressive symptoms were associated with greater stress-related increases 
in circulating inflammatory markers among adolescents with greater adiposity (Chiang et al., 
2017), higher levels of CRP among those with low parental support (Guan et al., 2016), and 
upregulated expression of inflammation-related genes and downregulated expression of antiviral-
related genes (Chiang et al., 2019b). Taken together, these findings demonstrate associations 
between inflammatory markers and indicators of depressive symptoms or distress among 
otherwise healthy youth.  
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Extant research on immune-to-brain signaling in humans demonstrated that, compared to 
placebo, inflammatory challenge was associated with heightened neural reactivity to negative 
social experiences in regions implicated in socioemotional and pain processing, particular in the 
dorsal anterior cingulate cortex (dACC), anterior insula, amygdala, and MPFC (Eisenberger et 
al., 2009, 2017; Inagaki et al., 2012; Muscatell et al., 2016). Moreover, those who showed 
greater increases in pro-inflammatory cytokines in response to the inflammatory challenge 
showed greater activity in the dACC and anterior insula in response to social exclusion 
(Eisenberger et al., 2009) and increased depressed mood (Eisenberger, Inagaki, Mashal, & Irwin, 
2010; Moieni et al., 2015; Reichenberg et al., 2001). These studies suggest that inflammation 
might sensitize the brain to negative social experiences, including the social evaluative aspect of 
stress, which has implications for stress-related psychiatric disorders. In addition to heightened 
threat sensitivity, peripheral immune markers have also been shown to influence PFC structure 
and associated functioning. For example, inflammation has been associated with smaller MPFC 
volume (Marsland et al., 2008) and reduced subgenual cingulate cortex connectivity to 
amygdala, MPFC, and nucleus accumbens in response to an affective processing task in adults 
(Harrison et al., 2009). Though not discussed further in the current study, inflammatory 
processes have also been shown to attenuate reward-related processes that underlie feelings of 
anhedonia (reviewed in Dantzer, O’Connor, Freund, Johnson, & Kelley, 2008; Eisenberger et al., 
2017; Nusslock & Miller, 2016). A meta-analysis on the associations between peripheral 
immune markers and brain function in adults revealed that inflammatory markers showed 
consistent effects in limbic and basal ganglia regions (amygdala, hippocampus, striatum, 
thalamus), brainstem regions, cortical regions (ACC, DMPFC, VMPFC, OFC, insula), and 
temporal regions (Kraynak, Marsland, Wager, & Gianaros, 2018). Given the protracted 
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development of the PFC into adulthood, the implications of inflammatory processes sensitizing 
an already sensitive limbic system in conjunction with diminishing function of a developing 
regulatory system for mental and physical health warrants further research in adolescents. 
However, there are virtually no studies, to my knowledge, that have investigated the associations 
between inflammatory processes and frontolimbic circuitry function in adolescents. One study 
that examined the associations between peripheral inflammatory markers and resting-state 
functional connectivity in African American adolescents (13-14 years) found that higher levels 
of inflammation were associated with lower resting-state functional connectivity in the emotional 
regulation and central executive networks (Nusslock et al., 2019), suggesting that the PFC and 
regulatory processes may be targets of inflammation during adolescence. 
Although it is unknown if peripheral immune markers have differential associations with 
the brain during adolescence, peripheral changes in the modulators of the immune system (e.g., 
sex hormones, HPA axis) and substantial neural remodeling during adolescence suggest that 
differential effects are likely. That is, it is possible that inflammatory challenges during 
adolescence can have differential effects on brain development compared to those experienced 
earlier or later in development (Schwarz & Bilbo, 2013). Additional research is necessary to 
advance our understanding of the bidirectional effects of immune and brain development during 
adolescence.  
The goal of the current study was to characterize the associations between peripheral 
immune markers, depressive symptoms, and neural reactivity to a stressor in adolescents (14-15 
years). This age range represents a time when MDD prevalence and stress reactivity is increasing 
(Dahl & Gunnar, 2009; Romeo, 2010; Romeo et al., 2014; Stroud et al., 2009; Substance Abuse 
and Mental Health Services Administration, 2017). The current study utilized a) venipuncture 
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draws and multiplex immunoassays to assess plasma levels of multiple peripheral immune 
markers, b) a well-validated self-report measure of depression (CES-D) to assess depressive 
symptoms in adolescents, and c) a well-validated fMRI stressor task (Dedovic et al., 2005) to 
assess neural reactivity to stress. I hypothesized that higher levels of peripheral pro-inflammatory 
markers (e.g., IL-6, TNF-a) would be associated with heightened neural response to stress in 
regions previously shown to respond to stress (e.g., anterior insula, anterior cingulate cortex) 
and/or diminished response in prefrontal regions, which would be associated with higher levels 
of self-reported depressive symptoms. 
Methods 
Participants 
Self-report questionnaires, daily diary (used in studies 2 and 3), and neuroimaging data 
were collected from 40 adolescents (14.03-15.99 years, M = 15.076, SD = 0.646, 17 females) 
who participated in a larger study conducted by Drs. Galván, Fuligni, and Eisenberger (NSF 
BSC 1551952). Participants were recruited using flyers posted on university campus, in local 
child and adolescent-friendly locations, on community websites (e.g., Craigslist), and flyer 
distributions at local high schools. Inclusion criteria required all participants be right-handed, 
free from metal objects in the body, speak fluent English, be in the appropriate age range, and 
have no previously diagnosed psychiatric, neurological, or developmental disorders. Parents of 
adolescent participants provided written consent and adolescents provided assent in accordance 
with the University of California, Los Angeles (UCLA) Institutional Review Board. Participants 
were also provided the opportunity to consent to an optional blood draw. All participants were 
compensated for their participation.  
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Of the 40 participants, one participant was excluded from neuroimaging analyses due to a 
neuroanatomical abnormality and two participants were excluded for excessive motion across 
both runs of the task. Of the remaining 37 (18 females) participants with usable neuroimaging 
data, 23 (62%; 9 females) participated in the blood draw. Four out of the 37 participants (which 
included two participants with blood data) did not complete measures of depressive symptoms. 
Analyses were conducted with the maximum number of subjects for each analysis. 
Procedure 
 Participants completed two visits at UCLA (Figure 2.1). During the first visit, after 
providing consent, participants completed questionnaires about demographic information and 
depressive symptoms and were trained on how to complete the daily diary measures. For 7 days 
after the first visit, participants received a text message each evening with a URL to an online 
survey asking about their day that they completed. After 7 days (but within two weeks), 
participants returned to UCLA to complete their second visit. Participants who consented to the 
blood draw had their blood drawn by a certified phlebotomist at the clinical lab in the Peter 
Morton Medical Building at UCLA. After the blood draw, participants completed a brain scan 
while performing the fMRI stressor task at the Center for Cognitive Neuroscience (CCN) at 
UCLA. Participants who did not consent to the blood draw only completed the brain scan portion 
of the study. Participants’ height and weight were measured to calculate body mass index (BMI). 
BMI ranged from 14.337 to 45.154 (M = 23.298, SD = 6.299). After the brain scan, participants 
completed additional questionnaires about their experiences regarding the stressor task, were 
debriefed about the goals of the study, and received compensation. 
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Figure 2.1. Schematic of experimental procedure. 
 
Measures 
Center for Epidemiological Studies – Depression (CES-D) Scale. Participants rated how 
often they felt or experienced 20 items that are indicative of depressive symptoms (e.g., “I felt 
that everything I did was an effort”, “I talked less than usual”, “I had crying spells”) on a 4-point 
scale (0 = rarely or none of the time, 3 = most or all of the time). Items on this scale were 
summed to create a composite score for each individual. CES-D scores of 16 or higher suggest 
clinical levels of depression. CES-D scores for our sample ranged from 2 to 51 (M = 13.06, SD = 
9.069). Eight (24%) participants reported CES-D scores of 16 or higher. CES-D scores did not 
differ by gender, t(30) = -1.565, p = .128. 
State Trait Anxiety Inventory (STAI). After the fMRI Stressor Task (described below), 
participants were asked to indicate to what extent (1 = not at all, 4 = very much so) they 
experienced 15 items relating to positive and negative affect and psychosomatic symptoms 
during the test trials of the task (e.g., “I felt calm”, “My heart was beating fast”, “I felt nervous”). 
After reverse-coding positive items, items on this scale were summed to create an index of task-
related anxiety. Higher scores indicate greater anxiety symptoms. STAI scores ranged from 16 to 
41 (M = 26.54, SD = 5.615). 
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Perceived Task Difficulty and Self-Rated Performance. After the fMRI Stressor Task, 
participants were asked to indicate how much control they felt they had during the test, how 
evaluated, effortful, challenging, threatening, and difficult they found the test trials of the task to 
be (1 = not at all, 7 = very much so) as well as how well they thought they did on the test overall 
(1 = not well at all, 7 = very well). Items were averaged to create an index of perceived task 
stressfulness. Higher scores indicate greater stress. Scores ranged from 2.833 to 5.667 (M = 
4.338, SD = .8045) for task stressfulness. Participants self-rated performance on the test ranged 
from 1 to 7 (M = 3.32, SD = 1.415). 
Immunological Measures 
 Blood samples were collected in EDTA tubes. After collection, samples were centrifuged 
at 4°C, plasma were harvested into multiple aliquots, and stored in a -80°C freezer until all blood 
samples for the study have been collected. All plasma samples from a single subject were 
assayed together on the same 96-well plate to minimize effects of inter-assay variation. All 
samples were assayed in duplicate and an internal quality control sample was included on every 
plate. IL-6, IL-8, IL-10, TNF-a, and IFNg were measured in a multiplex assay utilizing a V-
PLEX Custom Human Cytokine Proinflammatory Panel on the Meso Scale Discovery (MSD) 
electrochemiluminesence platform (MSD, Rockville, MD).  Samples were assayed at a 2-fold 
dilution according to the manufacturer’s protocol, with an eight-point standard curve with 
tripling dilutions.  Analyte-specific lower limits were calculated for each assay plate (IL-6: 0.21 
pg/mL, IL-8: 0.17 pg/mL, IL-10: 0.11 pg/mL, TNF-a: 0.11 pg/mL, IFNg: .42 pg/mL). For all 
plasma biomarkers, inter-assay coefficients of variation were less than or equal to 10% and mean 
intra-assay coefficients of variation were less than 6.5%. 
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 After excluding one subject with an acute viral infection and extreme value on IFNg 
(40.49 pg/mL), values for immune markers were natural log-transformed to correct for non-
normality. Descriptive statistics and bivariate correlations between immune markers and BMI are 
displayed in Table 2.1. Levels of immune markers did not differ by gender (p’s > .26). 
 
 M (SD) TNF-a IL-8 IL-10 IFNg BMI 
IL-6 0.591 (.704) .140 -.037 .131 .247 .719** 
TNF-a 2.031 (.329)  .140 .160 .073 -.123 
IL-8 3.959 (3.555)   -.272 -.208 .007 
IL-10 0.264 (.0873)    .368 -.074 
IFNg 5.066 (2.561)     .136 
BMI 23.30 (6.39)      
 
Table 2.1. Bivariate correlations between peripheral immune markers and BMI. Descriptive 
statistics are presented in raw values. Correlations were conducted using natural log-transformed 
values. ** p < .01 
 
fMRI 
fMRI Stressor Task. The current study used a modified version of the well-validated 
Montreal Imaging Stress Task (MIST) (Dedovic et al., 2005) task. On the stressor task, 
participants were asked to perform a series of mental arithmetic challenges that have social 
evaluative components integrated into the task (Figure 2.2). To assess the effects of stress, the 
stressor task consisted of 2 experimental conditions (practice and test) that were presented in an 
alternating block design. In the practice condition, participants completed a series of easy mental 
arithmetic problems on the computer screen. Each series or block contained 6 trials. On practice 
trials, easy arithmetic problems with no answer choices were shown. Participants were given 5 
seconds to solve each problem and were told to press 1 once they mentally solved each problem. 
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In the test condition, participants completed a series of challenging mental arithmetic problems 
on the computer screen. Each series or block contained 6 trials. On test trials, challenging 
arithmetic problems with 4 possible answer choices were presented to participants and they had 5 
seconds to choose the correct answer before time ran out. The difficulty of the problems in the 
test condition were chosen to be just slightly beyond individuals’ mental capacity to solve within 
the time limit, though it is possible to solve the problems within the time limit. After each 
arithmetic problem in the test condition, participants were shown feedback on their performance 
(i.e., “correct”, “incorrect”, or “out of time” if participants did not choose an answer in time). At 
the end of each test block, participants were shown a rating scale of their performance relative to 
that of their peers to increase the social evaluative threat of the task. This performance evaluation 
rating was manipulated by the experimenters such that the participants’ performance evaluation 
rating was declining over time and at a faster rate than that of their peers. Participants were told 
that the performance rating takes into account their accuracy and speed on the test trials to 
circumvent suspicion of deception in those who may have greater accuracy. After each 
experimental block, participants were asked to rate their stress levels (1 = not at all stressful, 4 = 
very stressful). Participants performed 4 practice blocks and 4 test blocks that alternated in 
sequence. 
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Figure 2.2. Diagram of the fMRI Stressor Task. 
 
One of the goals of the larger study was to assess the effect of stress on giving behavior. 
As such, the stressor task was modified to include blocks of a Dictator-type game where 
participants were asked to make decisions to accept or reject certain monetary offers. The 
decision blocks occurred after each alternating practice and test block. A rest period of 10 
seconds occurred between each decision block and the subsequent practice or test block where 
participants looked at a static computer screen on which no tasks were shown. Decision blocks 
were modeled but not analyzed in the current study. Participants completed two functional runs 
of approximately 8 minutes each. 
fMRI Data Acquisition. Functional imaging data were collected on a 3 Tesla Siemens 
Magnetom Prisma MRI scanner with a 20-channel head coil using a gradient-echo, echo-planar 
image (EPI) sequence (TR = 2000 ms, TE = 30 ms, flip angle = 90 degrees, FOV = 192 mm, 260 
volumes, 34 slices, slice thickness = 4 mm). A T2-weighted, matched bandwidth (MBW), high-
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resolution anatomical scan (TR = 5000ms, TE = 35ms, FOV = 192mm, flip angle = 90 degrees, 
34 slices, slice thickness = 4.0 mm) and magnetization-prepared rapid-acquisition gradient echo 
(MPRAGE) scan were acquired for registration purposes (TR = 2000 ms, TE = 2.52 ms, FOV = 
256 mm, matrix =, sagittal plane, slice thickness = 1 mm, 192 slices). 
fMRI Preprocessing. Preprocessing and statistical analyses were performed using 
FMRIB’s Software Library (FSL) 5.0.9. Preprocessing included motion correction, non-brain 
matter removal using FSL brain extraction tool (BET), spatial smoothing (5mm FWHM 
Gaussian kernel) to increase the signal-to-noise ratio and filtered in the temporal domain using a 
nonlinear high-pass filter (100s). Images with greater than 10% of TRs indicating framewise 
displacement > .9 mm were excluded from analyses. EPI images were registered to the MBW 
scan, then to the MPRAGE scan, and finally into standard Montreal Neurological Institute (MNI) 
space (MNI152, T1 2mm) using linear registration with FSL FMRIB’s Linear Image 
Registration Tool (FLIRT). 
Analytic Plan 
 All reported analyses covaried for gender. All analyses consisting of peripheral immune 
markers additionally covaried for body mass index (BMI). 
Regression analyses were used to relate participants’ levels of peripheral immune 
markers to depressive symptoms, controlling for gender and BMI. 
Behavioral Analysis of Stressor Task. Repeated-measures analyses of covariance 
(ANCOVAs) were used to test the effect of stress condition (practice vs. test blocks) on stress 
ratings to confirm that participants indeed found the test blocks to be more stressful than the 
practice blocks. Response time to solve arithmetic problems between stress conditions were also 
compared to confirm that test trials were more challenging than practice trials. Additional 
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ANCOVAs and regression analyses were conducted to determine whether stress ratings, 
behavior on stressor task, participants’ responses to the test-related STAI, and post-task 
questionnaire differed by depressive symptoms and peripheral immune markers. 
fMRI Data Analysis. Imaging data were modeled using a block design. General linear 
models (GLM) with multiple explanatory variables (regressors) were used for fMRI analyses. 
For each run, 4 explanatory variables were modeled: 1) practice blocks; 2) test blocks; 3) 
decision blocks; 4) instruction and stress rating screens. Each explanatory variable was 
convolved with a canonical double-gamma hemodynamic response function (HRF). Onset time 
for practice and test blocks were defined as the onset of the first arithmetic problem in each 
block. Onset time for decision blocks was defined as the onset of the first decision trial. Offset 
time for practice blocks was defined as the offset of the last arithmetic problem in the practice 
block. Offset time for each test block was defined as the offset of the performance rating screen 
(Inagaki et al., 2016). Offset time for decision blocks was defined as the offset of the last 
decision trial. The duration of each block was the duration between each blocks’ respective onset 
and offset times. “Rest” screens were not explicitly modeled and therefore served as an implicit 
baseline. 
 Analyses focused on the contrast between test blocks and practice blocks (Test > 
Practice, Practice > Test). A fixed effects voxel-wise analysis combined each of the two runs at 
the second level. Regression analyses were conducted at the group level using the FMRIB local 
analysis of mixed effects (FLAME1) module in FSL with mean-centered regressors of interest 
(e.g., peripheral immune markers, depressive symptoms) entered in each respective model in 
whole brain analyses. Z (Gaussianized T) statistic images were thresholded at Z > 2.3 (unless 
otherwise noted) by a corrected cluster significant threshold of p < .05 using Gaussian Random 
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Field theory and corrected for family-wise errors. Anatomical localization within each cluster 
were obtained by searching within maximum likelihood regions from the FSL Harvard-Oxford 
probabilistic atlas. 
Region-of-interest (ROI) Analyses. In addition to whole-brain analyses, ROI analyses 
were also conducted in regions previously implicated in stress reactivity and regulation (e.g., 
dACC, left and right anterior insula, left and right amygdala, and left and right hippocampus). 
dACC and bilateral anterior insula ROIs were structurally defined using the Automated 
Anatomical Labeling (ALL) atlas. The dACC ROI combined Brodmann Areas 32 and 25 and 
used a rostral boundary of y = 36 and a caudal boundary of y = 0 (Dedovic, Slavich, Muscatell, 
Irwin, & Eisenberger, 2016). The anterior insula ROIs were constructed by dividing the AAL 
insula ROI at y = 0, approximately separating dysgranular and granular insula (Slavich, Way, 
Eisenberger, & Taylor, 2010). Amygdala and hippocampus ROIs were anatomically defined 
using the FSL Harvard-Oxford probabilistic atlas and thresholded at 50% (Figure 2.3). 
 
 
 
Figure 2.3. ROIs for ROI analyses 
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Results 
Depressive symptoms and inflammation 
 Controlling for gender and BMI, self-reported depressive symptoms were not associated 
with levels of TNF-a (B = -5.684, SE = 9.876, t(16) = -.575, p = .573), IFNg (B = -2.005, SE = 
3.977, t(16) = -.504, p = .621), IL-10 (B = -4.444, SE = 4.815, t(16) = -.923, p = .370), IL-8 (B = 
4.505, SE = 2.320, t(16) = 1.941, p = .070), or IL-6 (B = -1.969, SE = 2.705, t(16) = -.728, p = 
.477). 
Behavior on fMRI Stressor Task 
Stress ratings. Controlling for gender, repeated measures ANCOVA revealed that, on 
average, participants rated the test block (M = 2.899, SD = .644) as more stressful than the 
practice block (M = 1.578, SD = .618), F(1, 35) = 171.809, p < .001 (Figure 2.4A). Differences 
in stress ratings did not differ by depressive symptoms (F(1, 30) < .001, p = .987), though 
adolescents who reported greater depressive symptoms reported higher stress ratings overall 
(F(1, 30) = 7.774, p = .009). Controlling for gender and BMI, differences in stress ratings did not 
differ by levels of TNF-a (F(1, 18) = .477, p = .499), IFNg (F(1, 18) = 1.175, p = .293), IL-8 
(F(1, 18) = .120, p = .733), or IL-6 (F(1,18) = .070, p = .794. Controlling for gender and BMI, 
adolescents with higher levels of IL-10 showed smaller differences in stress ratings between test 
and practice (F(1, 18) = 4.667, p = .044); however, simple slopes between IL-10 and stress 
ratings were not significant (practice: B = .264, SE = .281, t(18) = .940, p = .360; test: B = -.632, 
SE = .434, t(18) = -1.456, p = .163). 
Response time. On average, controlling for gender, participants took longer to respond to 
test problems (M = 3.535 seconds, SD = .399) than practice problems (M = 2.054 seconds, SD = 
.531), F(1, 33) = 376.046, p < .001 (Figure 2.4B). Controlling for gender, response time 
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difference did not differ by depressive symptoms (F(1, 28) = .850, p = .364). Controlling for 
gender and BMI, response time difference did not differ by levels of TNF-a (F(1, 18) = .142, p = 
.711), IFNg (F(1, 18) = .045, p = .834), IL-10 (F(1, 18) = 1.455, p = .243), IL-8 (F(1, 18) = .490, 
p = .493), or IL-6 (F(1, 18) = 2.656, p = .121). 
Test Accuracy. Accuracy on test problems ranged from 0% to 87.5% (M = 44.6%, SD = 
19.79%). Controlling for gender, adolescents who reported higher stress ratings on the test had 
lower test accuracy (B = -.123, SE = .048, t(34) = -2.536, p = .016). Adolescents who responded 
faster on test trials (B = -.192, SE = .079, t(32) = -2.149, p = .021) and practice trials (B = -.215, 
SE = .051, t(32) = -4.197, p < .001) had greater accuracy on the test. Controlling for gender, test 
accuracy did not differ by depressive symptoms (B = -.002, SE = .004, t(30) = -.483, p = .632. 
Controlling for gender and BMI, test accuracy did not differ by levels of TNF-a (B = .162, SE = 
.268, t(18) = .604, p = .553), IFNg (B = .068, SE = .100, t(18) = .679, p = .506, IL-10 (B = -.008, 
SE = .131, t(18) = -.057, p = .955), IL-8 (B = .074, SE = .068, t(18) = 1.082, p = .293), IL-6 (B = 
-.063, SE = .074, t(18) = -.857, p = .403). 
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Figure 2.4. Stress ratings (A) and response times (B) as a function of task condition. * p < .05 
 
Evaluation of fMRI Stressor Task 
Anxiety. Anxiety symptoms were not related to test accuracy (B = -.005, SE = .006, t(34) 
= -.782, p = .439) or response times (practice RT: B = .754, SE = 1.811, t(32) = .416, p = .680; 
test RT: B = 1.266, SE = 2.454, t(32) = .516, p = .610). However, adolescents who endorsed 
higher stress ratings on the test also reported greater test-related anxiety (B = 5.292, SE = 1.200, 
t(34) = 4.411, p = < .001. Self-reported feelings of anxiety were not associated with depressive 
symptoms (B = .152, SE = .115, t(30) = 1.319, p = .197). Controlling for gender and BMI, test-
related anxiety symptoms were not associated with levels of TNF-a (B = 5.918, SE = 6.202, 
t(18) = .954, p = .353), IFNg (B = 1.756, SE = 2.336, t(18) = .752, p = .462, IL-10 (B = -3.847, 
SE = 2.944, t(18) = -1.307, p = .208), IL-8 (B = .036, SE = 1.656, t(18) = .021, p = .983, IL-6 (B 
= .498, SE = 1.759, t(18) = .283, p = .780). 
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Perceived Task Difficulty. Adolescents who thought the test trials were more 
difficult/challenging were less accurate on the test (B = -.081, SE = .039, t(34) = -2.098, p = 
.043), endorsed higher stress ratings on the test (B = .484, SE = .205, t(34) = 2.357, p = .024), 
and reported greater task-related anxiety (B = .083, SE = .021, t(34) = 3.974, p < .001. Perceived 
task stressfulness was not associated with depressive symptoms (B = .002, SE = .017, t(30) = 
.146, p = .885). Controlling for gender and BMI, perceived task stressfulness was not associated 
with levels of TNF-a (B = -1.027, SE = 1.052, t(18) = -.975, p = .342), IFNg (B = -.207, SE = 
.400, t(18) = -.517, p = .612), IL-10 (B = -.223, SE = .521, t(18) = -.429, p = .673), IL-8 (B = -
.099, SE = .280, t(18) = -.353, p = .728), IL-6 (B = .052, SE = .299, t(18) = .175, p = .863). 
Self-Rated Performance. Adolescents who reported greater test-related anxiety (B = -
.148, SE = .035, t(34) = -4.172, p < .001) and greater perceived test difficulty (B = -.818, SE = 
.260, t(34) = -3.143, p = .003) thought that they performed worse on the test. However, self-rated 
performance was not related to test accuracy (B = .012, SE = .024, t(34) = .515, p = .610). Self-
rated performance on the math test did not differ by depressive symptoms (B = -.053, SE = .028, 
t(30) = -1.872, p = .071). Controlling for gender and BMI, self-reported performance was not 
associated with levels of TNF-a (B = -.720, SE = 1.706, t(18) = -.422, p = .678), IFNg (B = -
.696, SE = .619, t(18) = -1.124, p = .276), IL-10 (B = -.339, SE = .827, t(18) = -.410, p = .687), 
IL-8 (B = .308, SE = .441, t(18) = .699, p = .494), IL-6 (B = .157, SE = .474, t(17) = .331, p = 
.745). 
Main effects of fMRI Stressor Task 
 On average, participants engaged lateral prefrontal regions (dorsolateral prefrontal cortex, 
middle frontal gyrus, inferior frontal gyrus), anterior cingulate gyrus, anterior insula, 
orbitofrontal cortex, thalamus, and visual cortex more during test blocks compared to practice 
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blocks (Test > Practice) (Figure 2.5, Table 2.2). In contrast, participants engaged medial 
prefrontal regions (left frontal pole, right ventromedial prefrontal cortex), left amygdala, left 
hippocampus, right posterior insula, right posterior cingulate gyrus, left angular gyrus, and left 
temporal pole more during practice than test blocks (Practice > Test) (Figure 2.6, Table 2.2). One 
sample t-tests of activation in ROIs during Test > Practice revealed that participants engaged 
dACC (M = .03533, SD = .0376, t(35) = 5.639, p < .001) and bilateral anterior insula (left: M = 
.0281, SD = .0385, t(35) = 4.375, p < .001; right: M = .0269, SD = .045, t(35) = 2.581, p = .001) 
more during test relative to practice block. In contrast, participants engaged bilateral amygdala 
(left: M = -.04055, SD = .0503, t(35) = -4.839, p < .001; right: M = -.0317, SD = .0518, t(35) = -
3.672, p = .001) and bilateral hippocampus (left: M = -.0240, SD = .0348, t(35) = -4.137, p < 
.001; right: M = -.0195, SD = .0352, t(35) = -3.324, p = .002) more during practice relative to 
test blocks (Figure 2.7). 
 Regression analyses were conducted to determine whether activation in ROIs (dACC, 
bilateral anterior insula, bilateral amygdala, bilateral hippocampus) were associated with task 
behavior and evaluation. Controlling for gender, analyses revealed that greater dACC activation 
during Test > Practice was marginally associated with greater test accuracy (B = 1.658, SE = 
.850, t(33) = 2.1.951, p =.060). Greater bilateral anterior insula activation during Test > Practice 
were associated with greater test accuracy (left: B = 2.065, SE = .819, t(33) = 2.521, p = .017; 
right: B = 1.655, SE = .719, t(33) = 2.302, p = .028) (Figure 2.8). Bilateral amygdala and 
bilateral hippocampus activation were not associated with test accuracy (ps > .681). In contrast, 
greater bilateral amygdala activation during Practice > Test were marginally associated with 
greater test-related anxiety (left: B = -31.487, SE = 16.547, t(33) = -1.903, p = .066; right: B = -
30.236, SE = 16.329, t(33) = -1.852, p = .073). Similarly, right hippocampus activation during 
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Practice > Test was also marginally associated with greater test-related anxiety (right: B = -
41.804, SE = 23.555, t(33) = -1.775, p = .085) (Figure 2.9). 
 
 
 
 
Figure 2.5. Whole-brain analyses revealed that, on average, adolescents engaged corticolimbic 
regions (DLPFC, MFG, IFG, dACC, anterior insula, and OFC) more during test relative to 
practice blocks, cluster-corrected at Z > 3.1, p < .05. 
 
 
 33 
 
Figure 2.6. Whole-brain analyses revealed that, on average, adolescents engaged VMPFC, 
amygdala, and hippocampal regions more during practice relative to test blocks, cluster-
corrected at Z > 3.1, p < .05. 
 
 
 
Figure 2.7. ROI analyses revealed significant activation in dACC and bilateral anterior insula 
during Test > Practice and significant activation in bilateral amygdala and hippocampus during 
Practice > Test.  
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Figure 2.8. Greater activation in dACC and bilateral anterior insula during Test > Practice were 
associated with greater test accuracy, controlling for gender. 
 
 
 
Figure 2.9. Greater activation in bilateral amygdala and hippocampus during Practice > Test 
were marginally associated with greater test-related anxiety, controlling for gender. 
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 Hemisphere Region x y z Z-max 
 
Test > Practice 
 L/R Occipital pole -18 -84 -10 7.99 
   18 -94 14 8.00 
Practice > Test 
 L Frontal pole -10 66 18 5.73 
 R VMPFC 6 26 -14 5.34 
 L Amygdala -20 -6 -22 5.90 
 L Hippocampus -28 -12 -24 5.87 
 R Posterior insula 34 -20 14 5.67 
 R Posterior cingulate 6 -16 46 5.98 
 R Precentral gyrus 18 -26 68 5.89 
 L Angular gyrus -56 -60 30 6.32 
 L Temporal pole -48 6 -36 6.10 
 
Table 2.2. Results from whole-brain analyses. Averaged across all participants, clusters of 
activation for Test > Practice and Practice > Test, cluster-corrected at Z > 3.1, p < .05. Note: x, y, 
and z refer to MNI coordinates, Z-max refers to peak level of activation intensity. L = left, R = 
right. 
 
Depressive symptoms and neural response to fMRI Stressor Task 
 Whole-brain analyses revealed no significant associations between depressive symptoms 
and neural activation during Test > Practice. ROI analyses revealed that depressive symptoms 
were not associated with dACC (B = -.001, SE = .001, t(30) = -1.604, p = .119), bilateral anterior 
insula (left: B = -.001, SE = .001, t(30) = -1.00, p = .325; right: B = -.001, SE = .001, t(30) = -
.935, p = .357), or bilateral amygdala (left: B = -.002, SE = .001, t(30) = -1.587, p = .123; right: 
B = -.002, SE = .001, t(30) = -1.068, p = .294), or bilateral hippocampus (left: B = -.001, SE = 
.001, t(30) = -1.427, p = .164; right: B = -.001, SE = .001, t(30) = -1.059, p = .298) activation 
during Test > Practice. 
Inflammatory markers and neural response to fMRI Stressor Task 
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IL-6. Whole-brain analyses revealed that levels of IL-6 were not associated with 
activation for Test > Practice contrast. ROI analyses revealed that IL-6 was not significantly 
associated with dACC (B = -0.021, SE = .015, t(18) = -1.462, p = .161), bilateral anterior insula 
(left: B = -0.018, SE = .017, t(18) = -1.047, p = .309; right: B = -0.026, SE = .020, t(18) = -1.308, 
p = .207), bilateral amygdala (left: B = -.028, SE = .018, t(18) = -1.1611, p = .125; right: B = -
.030, SE = .019, t(18) = -1.534, p = .142), or bilateral hippocampus (left: B = -.016, SE = .010, 
t(18) = -1.580, p = .132; right: B = -.021, SE = .012, t(18) = -1.672, p = .112) activation during 
Test > Practice. 
TNF-a. Whole-brain analyses revealed that levels of TNF-a were negatively associated 
with activation in right occipital cortex for Test > Practice contrast (Table 2.3). ROI analyses 
revealed that levels of TNF-a were not associated with dACC (B = -0.056, SE = .054, t(18) = -
1.034, p = .315), bilateral anterior insula (left: B = -0.058, SE = .062, t(18) = -.940, p = .360; 
right: B = -0.027, SE = .073, t(18) = -.371, p = .715), bilateral amygdala (left: B = -.034, SE = 
.068, t(18) = -.507, p = .619; right: B = -0.012, SE = .075, t(18) = -.161, p = .874) or bilateral 
hippocampus (left: B = -.019, SE = .039, t(18) = -.494, p = .627; right: B = -.042, SE = .047, 
t(18) = -.890, p = .385) activation during Test > Practice. 
IL-10. Whole-brain analyses revealed that levels of IL-10 were not associated with 
activation for Test > Practice contrast. ROI analyses revealed that levels of IL-10 were not 
significantly associated with dACC (B = -.004, SE = .027, t(18) = -0.144, p = .887), bilateral 
anterior insula (left: B = .014, SE = .030, t(18) = .446, p = .661; right: B = .003, SE = .036, t(18) 
= .083, p = .935), or bilateral amygdala (left: B = .003, SE = .033, t(18) = .080, p = .937; right: B 
= -0.020, SE = .036, t(18) = -0.558, p = .584), bilateral hippocampus (left: B = -.015, SE = .019, 
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t(18) = -.786, p = .442; right: B = -.026, SE = .023, t(18) = -1.132, p = .273) activation during 
Test > Practice. 
IL-8. Whole-brain analyses revealed that levels of IL-8 were positively associated with 
activation in left superior frontal gyrus, left precentral gyrus, left postcentral gyrus, left superior 
parietal cortex, right lingual gyrus, and left lateral occipital cortex for Test > Practice contrast 
(Table 2.3). ROI analyses revealed that levels of IL-8 were not significantly associated with 
dACC (B = .001, SE = .015, t(18) = .079, p = .938), bilateral anterior insula (left: B = -.009, SE 
= .016, t(18) = -0.577, p = .571; right: B = -.004, SE = .019, t(18) = -.220, p = .828), bilateral 
amygdala (left: B = .008, SE = .018, t(18) = .455, p = .654; right: B = .026, SE = .018, t(18) = 
1.385, p = .183), bilateral hippocampus (left: B = .009, SE = .010, t(18) = .896, p = .382; right: B 
= .014, SE = .012, t(18) = 1.174, p = .256) activation during Test > Practice. 
IFNg. Whole-brain analyses revealed that levels of IFNg were negatively associated with 
activation in right postcentral gyrus, bilateral precuneous, and occipital regions for Test > 
Practice contrast (Table 2.3). ROI analyses revealed that levels of IFNg were marginally 
negatively associated with dACC activation during Test > Practice (B = -0.035, SE = .019, t(18) 
= -1.847, p = .081). IFNg was not associated with bilateral anterior insula (left: B = -0.015, SE = 
.023, t(18) = -0.644, p = .528; right: B = -0.013, SE = .027, t(18) = -0.464, p = .648), bilateral 
amygdala (left: B = .004, SE = .025, t(18) = .154, p = .880; right: B = -0.034, SE = .027, t(18) = -
1.283, p = .216), or bilateral hippocampus (left: B = -.016, SE = .014, t(18) = -1.141, p = .269; 
right: B = -.017, SE = .018, t(18) = -.948, p = .356) activation during Test > Practice. 
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 Direction Hemisphere Region x y z Z-max 
 
Test > Practice 
        
TNF-a Negative R Lateral occipital cortex 38 -78 -12 4.22 
  R Lingual gyrus 14 -82 -12 3.94 
        
IL-8 Positive L Superior frontal gyrus -20 -8 72 3.64 
  L Superior parietal lobule -42 -44 62 3.88 
  L Precentral gyrus -38 -8 60 3.34 
  L Postcentral gyrus -48 -32 60 3.72 
  L Lateral occipital cortex -42 -88 -6 3.68 
  R Lingual gyrus 18 -52 0 3.60 
        
IFNg Negative L Lateral occipital cortex -36 -86 -18 4.20 
  L/R Precuneous -4 -66 30 3.62 
    2 -66 54 4.02 
  R Postcentral gyrus 40 -36 62 3.12 
        
 
 
Table 2.3. Results from whole-brain analyses. Associations between peripheral immune markers 
and neural activation during Test > Practice, cluster-corrected at Z > 2.3, p < .05. Note: x, y, and 
z refer to MNI coordinates, Z-max refers to peak level of activation intensity. L = left, R = right. 
 
Discussion 
The goal of the current study was to characterize the associations between peripheral 
immune markers, depressive symptoms, and neural reactivity to a stressor in adolescents (14-15 
years). Analyses revealed that self-reported depressive symptoms, as indexed by the CES-D 
scale, were not associated with peripheral immune markers (TNF-a, IFNg, IL-8, IL-10, or IL-6). 
While contrary to hypothesis, these findings are consistent with previous research showing that, 
in otherwise healthy adolescents, depressive symptoms were not related to baseline levels of IL-6 
or IL-6 reactivity to a laboratory stressor in late adolescents, but that greater depressive 
symptoms were only associated with greater IL-6 reactivity for adolescents with high adiposity 
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(Chiang et al., 2017), suggesting that associations between peripheral immune markers and 
depressive symptoms during adolescence are complex and may be conditional upon many 
factors.  
On the fMRI stressor task, adolescents endorsed higher stress ratings during test blocks 
relative to practice blocks and took longer to complete test trials than practice trials, indicating 
that the test trials were indeed more challenging and stressful than the practice trials. Adolescents 
who endorsed higher stress ratings were less accurate on the test, reported experiencing greater 
test-related anxiety, and thought the test trials were more difficult and challenging. However, 
whereas perceived task difficulty was negatively associated with test accuracy, test-related 
anxiety was not associated with accuracy, suggesting perhaps that feelings of anxiety regarding a 
challenge may not necessarily compromise performance on a challenge. In relation to immune 
markers, peripheral immune markers were not associated with task performance (stress ratings, 
response time, accuracy), reported test-related anxiety, perceived task difficulty, or self-rated 
performance.  The only exception was found for anti-inflammatory marker IL-10, whereby 
greater levels of IL-10 were associated with smaller difference in stress ratings between practice 
and test trials, suggesting smaller psychological stress reactivity to the task for those with greater 
levels of IL-10. 
In the brain, participants engaged regions in corticolimbic circuitry (DLPFC, MFG, IFG, 
OFC, dACC, anterior insula) more during test blocks relative to practice blocks, consistent with 
previous research that utilized this task in adults and adolescents to elicit stress (Inagaki et al., 
2016; Strang et al., 2011). Adolescents who exhibited greater dACC and bilateral anterior insula 
activation during stress (Test > Practice) were more accurate on the test. Activation in other 
regions during Test > Practice was not associated with task performance or task evaluation. The 
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anterior insula and dACC are part of the salience network (Seeley et al., 2007) and play a role in 
integrating cognitive, affective, and physiological processes to regulate autonomic responses to 
stress (Gianaros et al., 2005; Gianaros & Wager, 2015; Strang et al., 2011). Greater anterior 
insula activation might reflect better integration and control of the stress response, which was 
reflected in better performance on the test/stressor. However, dACC and anterior insula 
activation were not associated with psychological reactivity or affective responses to the stressor 
in the current study, in contrast to what previous studies in adults have found (e.g., Eisenberger 
et al., 2009). Future analyses that examine functional connectivity of the anterior insula with 
cortical/affective regions would provide insight into the mechanisms by which anterior insula 
activation relates to stressor performance. 
In contrast, participants engaged regions implicated in emotion/stress regulation 
(VMPFC, amygdala, hippocampus) more during periods of relatively low stress (Practice > 
Test). Greater activation in bilateral amygdala and hippocampus during Practice > Test were 
marginally associated with greater test-related anxiety. While this pattern of results was 
unexpected, these findings suggest that activation of these emotion regulation regions during 
lower relative to higher periods of stress might reflect the neural processes underlying stress 
recovery or anticipation. Additionally, that greater amygdala and hippocampus activation during 
low stress were associated with greater test-related anxiety suggest that greater engagement of 
these regions under conditions of relatively lower stress may reflect protracted affective recovery 
from stress in adolescents. Previous research that utilized the MIST showed that, in a sample of 
adults, greater amygdala, VMPFC, DMPFC, and DLPFC activation during the stress condition 
relative to control (analogous to Test > Practice in the current study) were associated with greater 
changes in skin conductance response (an index of stress reactivity) and self-reported stress 
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(Orem et al., 2019), suggesting that variability in amygdala and PFC function may play a role in 
individual variability to psychological and physiological response to stress (LeDoux, Iwata, 
Cicchetti, & Reis, 1988; Ochsner et al., 2004). Future analyses that examine functional 
connectivity of the amygdala with PFC regions during stress reactivity (or recovery/anticipation) 
in comparison with an adult sample would provide insight into the functional networks that are 
relevant for stress processing for adolescents as well as whether these processes might differ 
developmentally from adults. 
In relation to immune markers, whole-brain and ROI analyses revealed no significant 
associations between peripheral immune markers and activation in corticolimbic circuitry during 
Test > Practice. Failure to detect significant associations could be attributed to several factors: 1) 
insufficient statistical power due to the small sample size; 2) the possibility that peripheral 
immune markers may be associated with network-level functional connectivity rather than 
regional activation during adolescents (e.g., Nusslock et al., 2019); 3) the possibility that the 
current fMRI task may not be sensitive to variability in immune markers in adolescents (e.g., 
previous studies that found associations between inflammation and brain function utilized 
threatening social stimuli such as negative facial expressions (Inagaki et al., 2012; Muscatell et 
al., 2016; Slavich et al., 2010); and 4) the possibility that the associations between peripheral 
immune markers and activation in corticolimbic circuitry may depend on other factors (i.e., 
moderators), which is explored in subsequent studies of the current dissertation. 
The current study also has additional limitations that should be considered. First, the 
cross-sectional and correlational study design precludes drawing any conclusions about causality 
or directionality of the relation between immune markers and brain function. Second, the age-
range of our adolescents was restricted to 14-15 years of age, which precludes generalization of 
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our findings to younger or older adolescents. There also may have been self-selection bias of 
subjects, as immune data were only available from those who opted in for the blood draw. 
Additionally, while we have good variability in self-reported depressive symptoms, only a small 
proportion (24%) of our sample reported depressive symptoms that would meet and exceed the 
clinical threshold. Moreover, adolescents tend to have relatively intact immune systems that keep 
inflammatory activity from fostering a chronic inflammatory state, therefore having relatively 
low levels of inflammation (Miller & Chen, 2010). As a result, our sample may have had 
restricted range for discovery of substantial mind/brain-body associations. However, whereas 
Chiang et al., (2017) did not find associations between depressive symptoms and peripheral 
levels of IL-6, Chiang et al., (2019b) found that depressive symptoms was associated with 
transcriptional profiles of immune cells, specifically gene expression of the conserved 
transcriptional response to adversity (CTRA) pattern (i.e., upregulation of pro-inflammatory 
gene expression and downregulation of antiviral gene expression) in a sample of late adolescents. 
These findings suggest that the expression of inflammation-related genes may represent a 
multitude of pro-inflammatory signals beyond IL-6 and may be sensitive enough to detect in 
otherwise healthy youth. Moreover, whereas gene expression is probed specifically in immune 
cells, the cellular origins of circulating IL-6 cannot be precisely determined as multiple tissues 
release IL-6, which confounds circulating immune markers in the periphery with immune 
function. Future research with larger samples, that utilize a longitudinal design, and probe both 
circulating levels of cytokines as well as gene expression of cytokines immune cells in addition 
to utilizing rigorous neuroimaging techniques would be well-positioned to elucidate the mind-
body connection across development in health and disease. 
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Despite these limitations, the current study was one of the first studies to investigate the 
associations between peripheral immune markers (using a multiplex immunoassay) and brain 
function in adolescents. While no significant associations between peripheral immune markers 
and corticolimbic activation during stress were detected, the current study contributes to the 
literature by demonstrating that frontolimbic activation during periods of low relative to high 
stress may play an informative role in understanding stress-related anxiety in otherwise healthy 
adolescents. 
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Chapter 3. Daily affective experiences moderate associations between immune markers and 
activation in corticolimbic circuitry during stress 
One characteristic of adolescence is the pubertal-driven change in stress reactivity. 
Adolescents report perceiving and experiencing more stress and show heightened and protracted 
HPA activity in response to stress relative to individuals in other developmental stages (Dahl & 
Gunnar, 2009; Romeo, 2013; Romeo et al., 2014; Stroud et al., 2009). These changes have 
implications for prolonging the effects of stress on brain and immune function. Indeed, animal 
research has shown that adolescent animals exhibit greater neural activity in the paraventricular 
nucleus (PVN) of the hypothalamus in response to stress (Romeo et al., 2006; Viau, Bingham, 
Davis, Lee, & Wong, 2005) as well as less effective glucocorticoid-dependent negative feedback 
of the HPA axis compared to adult rats (Goldman, Winget, Hollinshead, & Levine, 1973). 
The frequency and type of stressors can shape one’s hormonal response to stress 
(Grissom & Bhatnagar, 2009). For example, repeated exposure to the same stressor (homotypic 
stress) can lead to a habituated hormonal response compared to novel exposure to that stressor 
(Romeo et al., 2006). However, after repeated exposure to the same stressor, the introduction of a 
novel stressor (heterotypic stress) induces a heightened HPA response compared to that elicited 
by the novel stressor alone. Interestingly, this pattern of response to stressors is different between 
adults and adolescents. Whereas homotypic stress leads to habituation in adults, pre-adolescent 
males do not show similar patterns of habituation (Lui et al., 2012). Moreover, while heterotypic 
stress induces similar peak response for both age groups, pre-adolescent animals show slower 
recovery compared to adults (Lui et al., 2012). It has been suggested that these age-related 
differences in HPA function might be mediated by greater PVN activation after both homotypic 
and heterotypic stress during adolescence compared to adulthood (Lui et al., 2012). These animal 
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models suggest that adolescents are likely to be exposed to more stress-related hormones than 
adults when confronted with similar acute or repeated stressors. Indeed, work in humans has 
shown that adolescents (13-17 years of age in Stroud et al., 2009 and 15 years of age in Dahl & 
Gunnar, 2009) exhibited greater cortisol reactivity to laboratory stress compared to children (7-
12 years in Stroud et al., 2009; 9-13 years of age in Dahl & Gunnar, 2009). These ontogenetic 
changes in HPA function have implications for immune function and inflammation-related 
effects on brain and behavior during adolescence. Animal research has demonstrated that the 
effects of an inflammatory challenge on sickness behavior and increased mRNA expression of 
inflammatory proteins (e.g., IL-1b, IL-6, TNF-a) in the hippocampus and PFC were augmented 
in animals that experienced psychosocial stress (Gibb, Hayley, Gandhi, Poulter, & Anisman, 
2008; Gibb, Hayley, Poulter, & Anisman, 2011). That is, psychosocial stress enhanced the 
effects of inflammation on brain and behavior. It is yet unknown whether this interactive effect is 
also observed during adolescence. 
Extant studies that examined the associations between stress and immune function during 
adolescence have found that greater frequency of daily interpersonal stress was associated with 
elevated levels of CRP in adolescents one year later (Fuligni et al., 2009). In contrast, other 
studies have found that daily interpersonal stress was not concurrently associated with circulating 
levels of CRP (Chiang et al., 2015) or IL-6 reactivity to a laboratory-based stressor (Chiang et 
al., 2017). However, greater daily interpersonal stress was associated with greater pro-
inflammatory gene expression and inflammatory transcription factor (NF-kB) activity (Chiang et 
al., 2019a). These findings suggest that frequent daily stressors may affect upstream molecular 
inflammatory processes at the genomic level that may translate to changes in downstream 
circulating markers later. In addition to experiencing daily stressors, examining associations 
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between negative affect and affective reactivity (i.e., changes in negative affect in relation to 
those stressors) and immune processes would provide novel insight into the links between daily 
affective experiences and immunity during adolescence. 
Very little is known about how stressors and immune processes affect brain structure and 
function during adolescence. There is a need to fill this gap considering growing evidence of a 
hyper-responsive stress system during adolescence and the strong evidence that the brain regions 
known to be most sensitive to stress in adulthood (e.g., hippocampus, PFC, amygdala) continue 
to develop during adolescence (Giedd & Rapoport, 2010; Lupien et al., 2009; McEwen & 
Morrison, 2013). Animal studies have begun to shed light on these questions and provide a 
springboard from which we can begin to assess these questions in humans. For example, male 
rats exposed to chronic variable stress (daily exposure to physical stressors) throughout 
adolescence (for 4 weeks) showed initial increases in hippocampal volume (only in CA1), but 
exhibited impairment in volumetric growth in CA1, CA3, and dentate gyrus three weeks after 
stress termination compared to controls (Isgor et al., 2004). These structural changes were related 
to spatial impairments (Isgor et al., 2004). In another study, rats exposed to chronic restraint 
stress for 6 hours per day for 21 days during adolescence exhibited elevated depressive and 
anxious behaviors in addition to reduced dendritic complexity of pyramidal neurons in the PFC 
while neurons in the basolateral amygdala showed increased complexity (Eiland et al., 2012). 
Finally, exposure to social stress (e.g., social instability, isolation) during adolescence (for 15 
days) have also led to decreases in hippocampal neurogenesis and survival (McCormick et al., 
2010). Taken together, these findings suggest that experience of daily stressors during 
adolescence (even without exposure to early life stress) has the potential to affect behavior and 
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brain development in limbic and cortical regions. What remains unknown is the role that immune 
processes might play in these stress-related changes in brain and behavior. 
The purpose of the current study was to investigate whether adolescents’ experiences of 
daily stressors, daily negative affect, and stressor reactivity (Lippold, Davis, McHale, Buxton, & 
Almeida, 2016) related to peripheral immune markers and neural response to stress. Adolescents’ 
levels of perceived stress were also examined to assess global levels of feelings of stress. It was 
hypothesized that adolescents who reported greater levels of perceived stress, endorsed more 
stressors, reported higher negative affect, and/or showed greater stressor reactivity across the 
week would exhibit higher levels of peripheral pro-inflammatory markers (e.g., IL-6, TNF-a), 
which would be associated with heightened neural response to stress. Additionally, in line with 
the idea that psychosocial stress may enhance the effects of inflammation on brain function, it 
was also hypothesized that daily experiences would moderate the associations between 
peripheral immune markers and neural response to stress in regions previously shown to respond 
to stress (e.g., anterior insula, anterior cingulate cortex, and prefrontal regions). 
Methods 
Participants 
Self-report questionnaires, daily diary, and neuroimaging data were collected from 40 
adolescents (14.03-15.99 years, M = 15.076, SD = 0.646, 17 females) who participated in a 
larger study conducted by Drs. Galvan, Fuligni, and Eisenberger (NSF BSC 1551952). 
Participants were recruited using flyers posted on university campus, in local child and 
adolescent-friendly locations, on community websites (e.g., Craigslist), and flyer distributions at 
local high schools. Inclusion criteria required all participants be right-handed, free from metal 
objects in the body, speak fluent English, be in the appropriate age range, and have no previously 
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diagnosed psychiatric, neurological, or developmental disorders. Parents of adolescent 
participants provided written consent and adolescents provided assent in accordance with the 
University of California, Los Angeles (UCLA) Institutional Review Board. Participants were 
also provided the opportunity to consent to an optional blood draw. All participants were 
compensated for their participation.  
Of the 40 participants, one participant was excluded from neuroimaging analyses due to a 
neuroanatomical abnormality and two participants were excluded for excessive motion across 
both runs of the task. Of the remaining 37 (18 females) participants with usable neuroimaging 
data, 23 (62%; 9 females) participated in the blood draw. Four out of the 37 participants (which 
includes two participants with blood data) did not complete measures of perceived stress. 
Analyses were conducted with the maximum number of subjects for each analysis. 
Procedure 
 Participants completed two visits at UCLA. During the first visit, after providing consent, 
participants completed questionnaires about demographic information and depressive symptoms 
and were trained on how to complete the daily diary measures. For 7 days after the first visit, 
participants received a text message each evening with a URL to an online survey asking about 
their day that they completed. After 7 days (but within two weeks), participants returned to 
UCLA to complete their second visit. Participants who consented to the blood draw had their 
blood drawn by a certified phlebotomist at the clinical lab in the Peter Morton Medical Building 
at UCLA. After the blood draw, participants completed a brain scan while performing the fMRI 
stressor task at the Center for Cognitive Neuroscience (CCN) at UCLA. Participants who did not 
consent to the blood draw only completed the brain scan portion of the study. Participants’ height 
and weight were measured to calculate body mass index (BMI). BMI ranged from 14.337 to 
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45.154 (M = 23.298, SD = 6.299). After the brain scan, participants completed additional 
questionnaires about their experiences regarding the stressor task, were debriefed about the goals 
of the study, and received compensation. 
Measures 
Perceived Stress Scale (PSS). Participants rated how often in the last month they felt or 
experienced 10 items indicative of stress perception (e.g., “felt you were unable to control the 
important things in your life”, “felt nervous and stressed”) on a 5-point scale (0 = never, 4 = very 
often). Responses on each item were summed to create a composite score for each individual. 
PSS scores ranged from 4 to 32 (M = 17.03, SD = 6.682). 
Daily Stressors. Each night, participants were asked to indicate on a checklist whether 
they experienced stressful demands from various sources (e.g., a lot of work at school, a lot of 
demands made by my family) and arguments with various people (e.g., family member, friend). 
These events were selected because they represent psychological stressors for adolescents across 
domains of family, peers, and school (Chiang et al., 2015; Chung, Flook, & Fuligni, 2009; 
Nishina & Juvonen, 2005). Participants endorsed 0 to 3 stressors per day (average number of 
stressors endorsed per day = 0.6535, SD = 0.585). To capture the recurrence or chronicity of 
daily stress, a summary score reflecting the proportion of days participants experienced some 
degree of stress were calculated (Chiang et al., 2019a). Endorsed items were summed and 
recoded as 0 or 1 for each day to indicate whether any one of the stressors occurred that day. 
Recoded scores were then averaged across days to index the proportion of days that at least one 
stressor occurred. Proportions of daily stressors across the week ranged from 0.00 (no stressors 
endorsed during the week) to 1.00 (at least one stressor endorsed each day of the week) (M = 
.4342, SD = .2833).  
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Daily Affect. Each night, participants were asked to rate the extent to which they 
experienced six negative (e.g., on edge, sad, unable to concentrate, uneasy, hopeless, nervous) 
and eight positive (e.g., joyful, happy, calm, interested, excited, enthusiastic, cheerful, attentive) 
affect (1 = not at all, 5 = extremely). Items were taken from the Profile of Mood States (McNair, 
Lorr, & Droppleman, 1971) and the Positive and Negative Affect Schedule (Watson, Clark, & 
Tellegen, 1988). Previous studies that have used these items for daily diary showed good internal 
consistency of both negative affect (alpha = .94) and positive affect (alpha = .94) (Chiang et al., 
2015; Chiang, Kim, et al., 2017; Fuligni et al., 2009). Ratings for negative affect items were 
averaged across each day, which were then averaged across the week to obtain an index of 
average daily negative affect. Higher scores indicate greater average daily negative affect (range: 
1.033 – 3.833, M = 1.761, SD = .5677). 
Stressor Reactivity. Separate linear regression analyses (Negative Affectti = b0i + b1 
(Number of Daily Stressors)ti + eti) were conducted for each participant to calculate each 
person’s stressor reactivity (b1 = changes in negative affect on days when he or she endorses 
more daily stressors). Coefficients could not be calculated for 8 individuals because they did not 
endorse at least one stressor during the week (thus having zero variability in daily stressors for 
analyses). Higher stressor reactivity scores indicate greater increases in negative affect on days 
when individuals endorsed more stressors. Stressor reactivity ranged from -.7083 to 1.089 (M = 
.1676, SD = .4638).  
Immunological Measures 
A detailed description of blood sample collection, processing, and immunological assays 
are reported in the Methods: Immunological Measures section of Chapter 2/Study 1. 
fMRI 
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A detailed description of the fMRI Stressor Task, Data Acquisition, Data Preprocessing, 
and Level 1 analyses are previously reported in the Methods: fMRI section of Chapter 2/Study 1.  
Analytic Plan 
All reported analyses covaried for gender. All analyses consisting of peripheral immune 
markers additionally covaried for body mass index (BMI). 
Regression analyses were used to relate participants’ perceived stress, proportion of daily 
stressors, average daily negative affect, and stressor reactivity to levels of peripheral immune 
markers. 
Behavioral Analysis of Stressor Task. Repeated-measures ANCOVAs and regression 
analyses were conducted to determine whether stress ratings, behavior on stressor task, 
participants’ responses to the test-related STAI, and post-task questionnaire differed by 
perceived stress, proportion of daily stressors, average daily negative affect, and stressor 
reactivity. 
fMRI Data Analysis. A detailed description of level 1 analyses is previously reported in 
Methods: Analytic Plan section of Chapter 2/Study 1. Analyses focused on the contrast between 
test blocks and practice blocks (Test > Practice, Practice > Test). A fixed effects voxel-wise 
analysis combined each of the two runs at the second level. Regression analyses were conducted 
at the group level using the FMRIB local analysis of mixed effects (FLAME1) module in FSL 
with mean-centered regressors of interest (e.g., daily stressors, daily negative affect, stressor 
reactivity) entered in each respective model in whole brain analyses. Z (Gaussianized T) statistic 
images were thresholded at Z > 2.3 (unless otherwise noted) by a corrected cluster significant 
threshold of p < .05 using Gaussian Random Field theory and corrected for family-wise errors. 
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Anatomical localization within each cluster were obtained by searching within maximum 
likelihood regions from the FSL Harvard-Oxford probabilistic atlas. 
Average number of daily stressors, average daily negative affect, and participants’ 
stressor reactivity were entered as mean-centered regressors of interest in separate GLMs for 
whole-brain fMRI analyses to assess their associations with neural response to stress. 
Moderation analyses for each daily experience measure and each immune marker were 
conducted at the whole-brain level to assess whether daily affective experiences moderated 
associations between immune markers and neural response to stress. 
ROI Analyses. In addition to whole-brain analyses, ROI analyses were also conducted in 
regions previously implicated in stress reactivity and regulation (e.g., dACC, left and right 
anterior insula, left and right amygdala, and left and right hippocampus). A detailed description 
of the ROIs is previously reported in Methods: Analytic Plan section of Chapter 2/Study 1. 
Results 
 Bivariate correlations between perceived stress and daily measures are presented in Table 
3.1. Analyses revealed that greater levels of perceived stress were associated with greater 
average daily negative affect. There were no significant associations between daily stressors, 
negative affect, and stressor reactivity. 
 
 M (SD) Daily stressors Negative affect Stressor reactivity 
Perceived stress 17.03 (6.682) .035 .631** -.215 
Daily stressors .4342 (.2833)  .133 .216 
Negative affect 1.751 (.5677)   .160 
Stressor reactivity .1676 (.4638)    
 
Table 3.1. Bivariate correlations between perceived stress, proportion of daily stressors, average 
daily negative affect, and stressor reactivity. ** p < .001 
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Perceived stress and inflammation 
 Controlling for gender and BMI, greater perceived stress was associated with lower 
levels of IFNg (B = -8.366, SE = 3.475, t(16) = -2.408, p = .028). Perceived stress was not 
significantly associated with levels of TNF-a (B = -14.561, SE = 9.417, t(16) = -1.546, p = 
.142), IL-10 (B = -7.889, SE = 4.594, t(16) = -1.717, p = .105), IL-8 (B = 3.487, SE = 2.460, 
t(16) = 1.418, p = .175), or IL-6 (B = -4.265, SE = 2.570, t(16) = -1.660, p = .116). 
Daily stressors and inflammation 
 Controlling for gender and BMI, daily stressors were not associated with IFNg (B = .590, 
SE = .391, t(18) = 1.507, p = .149), IL-10 (B = -.169, SE = .318, t(18) = -.534, p = .600), IL-6 (B 
= -.029, SE = .559, t(18) = -0.053, p = .959), IL-8 (B = -.633, SE = .576, t(18) = -1.099, p = 
.286), or TNF-a (B = .109, SE = .153, t(18) = .710, p = .487). 
Negative affect and inflammation 
 Controlling for gender and BMI, greater negative affect was marginally associated with 
lower levels of IL-10 ((B = -0.272, SE = .155, t(18) = -1.757, p = .096). Negative affect was not 
associated with IFNg (B = .032, SE = .218, t(18) = .148, p = .884), IL-6 (B = -.085, SE = .293, 
t(18) = -.292, p = .774), IL-8 (B = .223, SE = .308, t(18) = .725, p = .478), or TNF-a (B = .015, 
SE = .081, t(18) = .180, p = .859). 
Stressor reactivity and inflammation 
 Controlling for gender and BMI, stressor reactivity was positively associated with IL-6 
(B = .662, SE = .253, t(15) = 2.620, p = .019). That is, adolescents who reported greater negative 
affect on days that they endorsed experiencing more stressors evinced greater levels of IL-6. 
Stressor reactivity was not associated with IFNg (B = -0.038, SE = .243, t(15) = -.156, p = .878), 
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IL-10 (B = -0.145, SE = .176, t(15) = -0.823, p = .423), IL-8 (B = -.340, SE = .299, t(15) = -
1.137, p = .273), TNF-a (B = .038, SE = .081, t(15) = .475, p = .642). 
Behavior on fMRI Stressor Task 
Stress ratings. Main effects of stress ratings were reported in Chapter 2/Study 1. 
Differences in stress ratings did not differ by perceived stress (F(1,30) = 1.755, p = .195), but 
adolescents who reported greater perceived stress reported higher stress ratings overall (F(1, 30) 
= 5.783, p = .023). Differences in stress rating did not differ by daily stressors (F(1, 33) = .329, p 
= .570), negative mood (F(1, 33) = .026, p = .874), or stressor reactivity (F(1, 33) = .040, p = 
.843). However, adolescents who reported greater negative affect reported higher stress ratings 
overall (F(1, 33) = 8.641, p = .006). 
Response time. Main effects of response time were reported in Chapter 2/Study 1. 
Controlling for gender, response time difference did not differ by perceived stress (F(1, 28) = 
.001, p = .979), daily stressors (F(1, 33) = 3.510, p = .070), or stressor reactivity (F(1, 25) = .002, 
p = .961). Adolescents who reported greater negative affect showed greater difference in 
response time between test and practice trials (F(1, 33) = 6.266, p = .017) and were faster overall 
(F(1, 33) = 4.362, p = .045).  
Test Accuracy. Controlling for gender, test accuracy did not differ by perceived stress (B 
= -.005, SE = .006, t(30) = -.943, p = .353), daily stressors (B = .129, SE = .124, t(33) = 1.042, p 
= .305), negative affect (B = .012, SE = .061, t(33) = .194, p = .847), or stressor reactivity (B = -
0.056, SE = .068, t(25) = -0.819, p = .420).  
Evaluation of fMRI Stressor Task 
Anxiety. Controlling for gender, adolescents who reported greater perceived stress 
reported experiencing greater test-related anxiety symptoms (B = .400, SE = .145, t(30) = 2.767, 
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p = .010). Adolescents who reported greater daily negative affect reported experiencing greater 
test-related anxiety symptoms (B = 4.311, SE = 1.558, t(33) = 2.766, p = .009). Test-related 
anxiety symptoms were not associated with daily stressors (B = 1.732, SE = 3.545, t(33) = .489, 
p = .628) or stressor reactivity (B = .550, SE = 2.217, t(25) = .248, p = .806).  
Perceived Task Difficulty. Controlling for gender, adolescents who reported greater 
perceived stress reported that they thought the test trials were more difficult/challenging (B = 
.052, SE = .021, t(30) = 2.500, p = .018). Perceived task difficulty was not associated with daily 
stressors (B = -0.036, SE = .511, t(33) = -0.071, p = .944), negative affect (B = .138, SE = .247, 
t(33) = .558, p = .581), or stressor reactivity (B = -0.182, p = .319, t(25) = -0.570, p = .574).  
Self-Rated Performance. Adolescents who reported greater perceived stress were more 
likely to report that they thought they performed worse on the test (B = -.088, SE = .038, t(30) = 
-2.336, p = .026). Self-rated performance was not associated with daily stressors (B = -1.545, SE 
= .868, t(33) = -1.779, p = .084), negative mood (B = -.626, SE = .428, t(33) = -1.463, p = .153), 
stressor reactivity (B = .453, SE = .485, t(25) = .934, p = .359).  
Main effects of fMRI Stressor Task 
 Detailed analyses of the main effects of fMRI Stressor Task were previously reported in 
Chapter 2/Study 1. Briefly, on average, participants engaged DLPFC, ACC, anterior insula, and 
OFC regions more during test blocks compared to practice blocks. Greater bilateral anterior 
insula (ROIs) activation during Test > Practice were associated with greater test accuracy. In 
contrast, participants engaged VMPFC, amygdala, hippocampus, and posterior cingulate regions 
more during practice blocks compared to test blocks. Greater bilateral amygdala and 
hippocampal activation (ROIs) during Practice > Test were marginally associated with greater 
test-related anxiety.  
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Perceived stress and neural response to fMRI Stressor Task 
Whole-brain analyses revealed that perceived stress was not associated with activation 
during Test > Practice. ROI analyses revealed that perceived stress was not associated with 
dACC (B = -.0003, SE = .001, t(30) = -.248, p = .806), bilateral anterior insula (left: B = -.0002, 
SE = .001, t(30) = -.146, p = .885; right: B < .001, SE = .001, t(30) = -.063, p = .950), bilateral 
amygdala (left: B = -.003, SE = .002, t(30) = -1.510, p = .142; right: B = -.002, SE = .002, t(30) 
= -.802, p = .429), or bilateral hippocampus (left: B = -.001, SE = .001, t(30)- = -.863, p = .395; 
right: B = -.001, SE = .001, t(30) = -.499, p = .621) activation during Test > Practice. 
Daily stressors and neural response to fMRI Stressor Task 
 Adolescents who reported greater proportion of daily stressors during the week showed 
greater frontostriatal activation (left frontal pole, OFC, and putamen) during Test > Practice 
(Table 3.2; Figure 3.1). Parameter estimates (5mm spheres around peak activation) from left 
frontal pole, OFC, and putamen were extracted to determine whether activation related to task 
behavior and evaluation. Controlling for gender and daily stressors, there were no significant 
associations between frontostriatal activation and task behavior or evaluation.  
ROI analyses revealed that daily stressors were positively associated with bilateral 
anterior insula activation during Test > Practice (left: B = .048, SE = .023, t(33) = 2.078, p = 
.046; right: B = .057, SE = .026, t(33) = 2.162, p = .038) (Figure 3.2). Controlling for gender and 
daily stressors, bilateral anterior insula activation was positively associated with test accuracy 
(left: B = 1.955, SE = .883, t(32) = 2.215, p = .034; right: B = 1.545, SE = .778, t(32) = 1.985, p 
= .056. Daily stressors were not significantly associated with dACC (B = .031, SE = .026, t(34) = 
1.185, p = .244), bilateral amygdala (left: B = -.025, SE = .040, t(34) = -.627, p = .535; right: B = 
-.037, SE = .046, t(34) = -.801, p = .428), or bilateral hippocampus (left: B = -.010, SE = .029, 
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t(34) = -.354, p = .725; right: B = -.005, SE = .030, t(34) = -.167, p = .868) activation during Test 
> Practice. 
 
 
 
 
 
Figure 3.1. Greater proportion of daily stressors was associated with greater activation in left 
frontal pole, OFC, and putamen during Test > Practice, cluster-corrected at Z > 2.3, p < .05. 
Scatterplots displayed for visual purposes. 
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Figure 3.2. ROI analyses revealed that daily stressors were positively associated with bilateral 
anterior insula during Test > Practice. 
 
Negative affect and neural response to fMRI Stressor Task 
 Lower negative affect was associated with greater activation in right prefrontal regions 
(DLPFC, MPFC, middle frontal gyrus, OFC), right superior frontal gyrus, right temporal pole, 
posterior cingulate, and left parahippocampal gyrus during Test > Practice (Table 3.2, Figure 
3.3). Parameter estimates (5mm spheres around peak activation) from right DLPFC, MPFC, and 
OFC were extracted to determine whether activation related to task behavior and evaluation. 
Controlling for gender and daily negative affect, greater levels of MPFC activation during Test > 
Practice were associated with lower perceived test difficulty (B = -7.117, SE = 3.036, t(33) = -
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2.344, p = .025) (Figure 3.4). Activation in DLPFC and OFC were not significantly associated 
with behavior or self-reported evaluation. 
 ROI analyses revealed that negative affect was negatively associated with dACC (B = -
.023, SE = .011, t(33) = -2.087, p = .045) and right anterior insula (B = -.026, SE = .013, t(33) = 
-1.984, p = .056) activation during Test > Practice, and positively associated with bilateral 
amygdala (left: B = -.046, SE = .014, t(33) = -3.352, p = .002; right: B = -.037, SE = .015, t(33) 
= -2.519, p = .017) and bilateral hippocampus (left: B = -.032, SE = .010, t(33) = -3.265, p = 
.003; right: B = -.027, SE = .010, t(33) = -2.650, p = .012) activation during Practice > Test 
(Figure 3.5). Negative affect was not significantly associated with left anterior insula (B = -.017, 
SE = .011, t(33) = -1.465, p = .152). Controlling for gender and negative affect, dACC (B = 
1.967, SE = .904, t(32) = 2.175, p = .037) and right anterior insula (B = 1.926, SE = .759, t(32) = 
2.538, p = .016) activation during Test > Practice were positively associated with test accuracy. 
Bilateral amygdala and hippocampus activation were not significantly associated with test-
related anxiety after controlling for negative affect (left amygdala: B = -14.641, SE = 18.536, 
t(32) = -.790, p = .435; right amygdala: B = -16.819, SE = 17.117, t(32) = -.983, p = .333; left 
hippocampus: B = -5.439, SE = 26.591, t(32) = -.205, p = .839; right hippocampus: B = -21.383, 
SE = 24.892, t(32) = -.859, p = .397). However, negative affect remained positively associated 
with test-related anxiety over and above bilateral amygdala and bilateral hippocampus activation 
(B – 3.324, SE = 1.745, t(29) = 1.905, p = .067). 
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Figure 3.3. Whole-brain analyses revealed that daily negative affect was negatively associated 
with activation in right DLPFC, MPFC and OFC during Test > Practice, cluster-corrected at Z > 
2.3, p < .05. Scatterplots displayed for visual purposes. 
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Figure 3.4. Controlling for gender and negative affect, greater levels of MPFC activation during 
Test > Practice were associated with lower perceived test difficulty. 
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Figure 3.5. ROI analyses revealed that negative affect was associated with dACC, right anterior 
insula, bilateral amygdala, and bilateral hippocampus activation during Test > Practice. 
 
Stressor reactivity and neural response to fMRI Stressor Task 
 Greater stressor reactivity was associated with lower activation in right middle temporal 
gyrus during Test > Practice (Table 3.2). 
 ROI analyses revealed that greater stressor reactivity was associated with lower (greater) 
bilateral amygdala (left: B = -.061, SE = .017, t(25) = -3.484, p = .002; right: B = -.058, SE = 
.020, t(25) = -2.843, p = .009) and bilateral hippocampus (left: B = -.026, SE = .013, t(25) = -
1.992, p = .057; right: B = -.039, SE = .014, t(25) = -2.812, p = .009) activation during Test > 
Practice (Practice > Test) (Figure 3.6). Stressor reactivity was not significantly associated with 
dACC (B = -.019, SE = .016, t(25) = -1.197, p = .243), bilateral anterior insula (left: B = -.011, 
SE = .016, t(265 = -.648, p = .523; right: B = -.028, SE = .019, t(25) = -1.527, p = .139) 
activation during Test > Practice. 
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Figure 3.6. ROI analyses revealed that stressor reactivity was negatively (positively) associated 
with bilateral amygdala and bilateral hippocampus activation during Test > Practice (Practice > 
Test). 
 
 Direction Hemisphere Region x y z Z-max 
 
Test > Practice 
        
Daily Stressors Positive L Frontal pole -40 44 14 3.13 
  L OFC -42 22 -6 3.46 
  L Putamen -22 14 4 3.19 
        
Negative Affect Negative R MPFC 10 48 14 4.26 
  R DLPFC 36 22 40 3.43 
  R Middle frontal gyrus 38 26 26 3.93 
  R Superior frontal gyrus 4 30 48 3.72 
  R OFC 40 24 -10 3.24 
  R Temporal pole 46 20 -16 3.50 
  R Superior temporal gyrus 54 -30 6 3.11 
  R Posterior cingulate  6 -20 44 3.73 
  L Parahippocampal gyrus -16 -36 -18 4.04 
        
Reactivity Negative R Middle temporal gyrus 50 -30 -6 3.78 
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Table 3.2. Associations between daily stressors, negative affect, and stressor reactivity on neural 
response to stress (Test > Practice), cluster-corrected at Z > 2.3, p < .05. Note: x, y, and z refer to 
MNI coordinates, Z-max refers to peak level of activation intensity. L = left, R = right. 
 
Immune markers and neural response to fMRI Stressor Task 
 Detailed analyses of the associations between immune markers and neural response to 
stress were previously reported in Chapter 2/Study 1. Briefly, levels of immune markers were not 
significantly associated with regions in corticolimbic circuitry during Test > Practice, precluding 
testing of mediation between daily affective experiences and neural response to stress by 
immune markers. Therefore, moderation analyses were conducted to determine whether the 
relation between peripheral immune markers and brain function depended on daily affective 
experiences.  
Interactions with peripheral immune markers 
Daily stressors. Whole-brain analyses testing for interactions between daily stressors and 
immune markers on neural response to stress (Test > Practice) revealed significant interactions 
between daily stressors and TNF-a in bilateral temporal poles; between daily stressors and IL-8 
in right superior frontal gyrus, precentral gyrus and bilateral occipital regions; and between daily 
stressors and IFNg in left parietal and occipital regions (Table 3.3). 
Negative affect. Whole-brain analyses testing for interactions between negative affect and 
immune markers on neural response to stress (Test > Practice) revealed significant interactions 
between IL-6 and negative affect in perigenual ACC, MPFC, and left lateral OFC during Test > 
Practice (Table 3.3, Figure 3.7). Parameter estimates (5mm spheres around peak activation) from 
perigenual ACC, MPFC, and left OFC were extracted to probe the nature of the interaction. 
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Follow up analyses revealed that among those who reported low negative affect (1 SD below 
mean = 1.1264), lower levels of IL-6 were associated with greater activation in perigenual ACC 
and MPFC during Test > Practice (ACC: B = -.0942, SE = .0256, t(16) = -3.6808, p = .002; 
MPFC: B = -.0650, SE = .0315, t(16) = -2.0626, p = .0558). Levels of IL-6 were not associated 
with perigenual ACC and MPFC activation among those who reported average levels of negative 
affect (mean negative affect = 1.611; ACC: B = -.0411, SE = .0217, t(16) = -1.8972, p = .0760; 
MPFC: B = -.0064, SE = .0267, t(16) = -.2416, p = .8122) or high levels of negative affect (1 SD 
above mean = 2.0958; ACC: B = .0119, SE = .0313, t(16) = .3800, p = .7090; MPFC: B = .0521, 
SE = .0386, t(16) = 1.3497, p = .1959) (Figure 3.7). In contrast, among those who reported high 
negative affect (1 SD above mean = 2.0958), greater levels of IL-6 was associated with greater 
activation in left lateral OFC during Test > Practice. IL-6 was not associated with left lateral 
OFC activation among those who reported average (B = .02224, SE = .0144, t(16) = 1.5580, p = 
.1388) or low levels of negative affect (B = -.0273, SE = .0170, t(16) = -1.6101, p = .1269) 
(Figure 8). Additionally, controlling for gender, BMI, daily negative affect, and levels of IL-6, 
greater OFC activation was associated with lower self-rated performance on the test (B = -
12.621, SE = 5.431, t(16) = -2.324, p = .034). 
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Figure 3.7. Daily negative affect moderated associations between IL-6 and activation in 
perigenual ACC, MPFC, and OFC during Test > Practice, cluster-corrected at Z > 2.3, p < .05. 
 
Analyses also revealed a significant interaction between TNF-a and negative affect in 
medial prefrontal regions (MPFC, left frontal pole, right medial OFC), left superior frontal gyrus, 
right temporal pole, and right occipital cortex during Test > Practice (Table 3.3, Figure 3.8). 
Parameter estimates (5mm spheres around peak activation) from MPFC, left frontal pole, and 
right medial OFC were extracted to probe the nature of the interaction. Follow up analyses 
revealed that among those who reported high negative affect, higher levels of TNF-a were 
associated with lower (greater) activation in MPFC, left frontal pole, and right OFC during Test 
> Practice (Practice > Test) (MPFC: B = -.5757, SE = .2015, t(16) = -2.8575, p = .011; frontal 
pole: B = -.2862, SE = .1292, t(16) = -2.2157, p = .0416; OFC: B = -.6002, SE = .1389, t(16) = -
4.3212, p = .0005). Levels of TNF-a were not significantly associated with MPFC activation 
during Test > Practice among those who reported low (B = .1838, SE = .2059, t(16) = .8926, p = 
.3853) or average levels of negative affect (B = -.1959, SE = .1337, t(16) = -1.4658, p = .1621). 
In contrast, among those who reported low negative affect, higher levels of TNF-a were 
associated with higher (lower) activation in left frontal pole and right OFC during Test > Practice 
(Practice > Test) (frontal pole: B = .2990, SE = .1320, t(16) = 2.2650, p = .0377; OFC: B = 
.3400, SE = .1420, t(16) = 2.3948, p = .0292) (Figure 3.8). Activation in these regions were not 
associated with task behavior or evaluation.  
There were no significant interactions between negative affect and IL-8, IL-10, or IFNg 
on neural response to stress (Test > Practice). 
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Figure 3.8. Daily negative affect moderated associations between TNF-a and activation in 
MPFC, left frontal pole, and right OFC during Test > Practice, cluster-corrected at Z > 2.3, p < 
.05. 
 
 Stressor reactivity. Whole-brain analyses testing for interactions between negative affect 
and immune markers revealed a significant interaction between IL-6 and stressor reactivity in 
left MPFC during Test > Practice (Table 3.3; Figure 3.9). Parameter estimates (5mm spheres 
around peak activation) from MPFC were extracted to probe the nature of the interaction. Follow 
up analyses revealed that among those who evinced average levels of stressor reactivity (mean = 
.1931), greater levels of IL-6 were associated with higher (lower) activation in MPFC during 
Test > Practice (Practice > Test) (B = .1064, SE = .0488, t(13) = 2.1818, p = .0481). This effect 
was stronger for those who evinced high stressor reactivity (1 SD above mean = .6647; B = 
.2988, SE = .0860, t(13) = 3.4743, p = .0041). Levels of IL-6 were not associated with MPFC 
activation for those who showed low stressor reactivity (1 SD below mean = -.2785; B = -.0860, 
SE = .0533, t(13) = -1.6117, p = .1310) (Figure 3.9). MPFC activation was not associated with 
task behavior or evaluation. 
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Figure 3.9. Stressor reactivity moderated associations between IL-6 and activation in MPFC 
during Test > Practice, cluster-corrected at Z > 2.3, p < .05. 
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 Analyses also revealed a significant interaction between IFNg and stressor reactivity in 
left pallidum, which extended out to left amygdala, and left putamen (Table 3.3; Figure 3.10). 
Parameter estimates (5mm spheres around peak activation) from left pallidum/amygdala and left 
putamen were extracted to probe the nature of the interaction. Follow up analyses revealed that 
among those with low stressor reactivity, greater levels of IFNg were associated with greater 
activation in left pallidum/amygdala (B = -.0975, SE = .0244, t(13) = -3.9953, p = .0015) and left 
putamen during Practice > Test (B = -.0433, SE = .0176, t(13) = -2.4612, p = .0286). In contrast, 
among those with high stressor reactivity, greater levels of IFNg were associated greater 
activation in left pallidum/amygdala (B = .0949, SE = .0320, t(13) = 2.9617, p = .0110) and left 
putamen (B = .0709, SE = .0231, t(13) = 3.0741, p = .0089) activation during Test > Practice 
(Figure 3.10). Levels of IFNg were not significantly associated with left pallidum or putamen 
activation during Test > Practice for those with average levels of stressor reactivity (pallidum: B 
= -.0013, SE = .0161, t(13) = -.0852, p = .9355; putamen: B = .0138, SE = .0116, t(13) = 1.1905, 
p = .255). Controlling for gender, BMI, stressor reactivity, and IFNg, greater activation in left 
pallidum/amygdala was associated with greater difference in stress ratings between test and 
practice blocks (F(1, 13) = 5.885, p = .031); this effect was driven by greater stress ratings of test 
blocks among those with greater left pallidum/amygdala activation during Test > Practice (B = 
9.253, SE = 2.614, t(13) = 3.540, p = .004 (Figure 3.11). 
There were no significant interactions between stressor reactivity and IL-8, IL-10, or 
TNF-a on neural response to stress (Test > Practice). 
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Figure 3.10. Stressor reactivity moderated associations between IFNg and activation in left 
pallidum/amygdala and left putamen during Test > Practice, cluster-corrected at Z > 2.3, p < .05. 
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Figure 3.11. Controlling for gender, BMI, negative affect, and levels of IFNg, greater activation 
in left pallidum/amygdala during Test > Practice was associated with greater stress reactivity 
(difference in stress ratings between test and practice blocks). 
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 Immune 
Marker 
Hemisphere Region x y z Z-max 
 
Test > Practice 
        
Daily Stressors TNF-a L/R Temporal pole -42 4 -22 3.36 
    48 16 -30 3.15 
        
 IL-8 R Precentral gyrus 28 -16 52 3.95 
  R Superior frontal gyrus 26 -6 60 3.25 
  R Lateral occipital cortex 56 -68 8 3.56 
  L Occipital pole -28 -92 28 4.56 
        
 IFNg L Lateral occipital cortex -38 -64 48 4.17 
  L Angular gyrus -44 -54 20 3.82 
        
        
Negative Affect IL-6 L Anterior cingulate -2 40 10 3.41 
  L MPFC -2 48 -2 3.33 
  L OFC -44 32 -6 3.60 
        
 TNF-a R OFC 22 24 -18 4.16 
  L Frontal pole -2 56 -18 3.45 
  L MPFC -8 64 4 3.34 
  L Superior frontal gyrus -2 40 52 3.53 
  R Temporal pole 40 18 -28 3.70 
        
 IFNg R Occipital pole 24 -98 6 3.49 
  R Lateral occipital cortex 46 -78 16 3.41 
        
        
Reactivity IL-6 L MPFC -2 54 -18 4.10 
        
 TNF-a L Lateral occipital cortex -48 -80 20 4.57 
        
 IL-8 L Lateral occipital cortex -42 -84 8 3.90 
        
 IL-10 L/R Occipital pole -10 -90 22 4.10 
    22 -90 26 4.23 
        
 IFNg L Pallidum -22 -12 -6 3.59 
  L Putamen -24 -8 10 2.79 
 
Table 3.3. Significant interactions between daily measures and peripheral immune markers on 
neural activation during Test > Practice, cluster-corrected at Z > 2.3, p < .05. Note: x, y, and z 
refer to MNI coordinates, Z-max refers to peak level of activation intensity. L = left, R = right. 
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Discussion 
The goal of the current study was to investigate whether adolescents’ perceived stress, 
experiences of daily stressors, daily negative affect, and stressor reactivity (Lippold et al., 2016) 
related to peripheral immune markers, neural response to stress, and whether these daily 
experiences moderated the associations between peripheral immune markers and neural response 
to stress. It was hypothesized that adolescents who reported greater levels of perceived stress, 
endorsed more stressors, reported higher negative affect, and/or showed greater stressor 
reactivity would exhibit higher levels of pro-inflammatory markers. Results revealed that greater 
perceived stress was associated with lower levels of IFNg. Results also revealed that stressor 
reactivity was positively associated with levels of IL-6. That is, adolescents who, on average, 
reported greater negative affect on days that they endorsed experiencing more stressors had 
higher levels of circulating IL-6. Stressor reactivity was not associated with any other immune 
markers. Additionally, greater negative affect was marginally associated with lower levels of 
anti-inflammatory markers, IL-10. Negative affect was not associated with other immune 
markers. Daily stressors were not associated with any of the immune markers. These findings 
suggest that experiences of normative stressors in daily life, such as demands from school or 
arguments with others, themselves may not necessarily have effects on immunity; rather, it is the 
negative appraisals and reactivity to the stressors that appear to have consequences for 
inflammation. These findings extend from previous research that reported elevated levels of 
inflammation and pro-inflammatory gene expression in relation to increased stress in adolescents 
(Chiang et al., 2019a; Fuligni et al., 2009) by demonstrating that stressor reactivity also relates to 
elevated levels of inflammation. The current study further extends previous research by showing 
 79 
that greater daily negative affect and greater levels of perceived stress were negatively associated 
with anti-inflammatory and antiviral processes, respectively. 
On the fMRI stressor task, adolescents who reported greater levels of perceived stress 
reported higher stress ratings overall, greater test-related anxiety symptoms, greater perceived 
task difficulty, and worse self-rated performance. Despite these elevated levels in negative 
evaluation and affect, levels of perceived stress were not related to test accuracy. Additionally, 
perceived stress was not associated with neural activation on the task. 
While proportion of daily stressors was not associated with behavior or participants’ self-
reported evaluation of the task, adolescents who reported more daily stressors showed greater 
frontostriatal (left lateral prefrontal and orbitofrontal cortex, left putamen) activation during Test 
> Practice. Activation in these regions were not associated with behavior or self-reported 
evaluation of the task. ROI analyses revealed that daily stressors were positively associated with 
bilateral anterior insula activation during Test > Practice, which were positively associated with 
greater test accuracy. These findings suggest that adolescents who experience more daily 
stressors recruit frontostriatal circuitry to a greater extent than those with fewer daily stressors 
when engaging with stress, which bolsters their performance in overcoming the stressor. Daily 
stressors did not moderate the associations between immune markers and neural activation in 
cortiocolimbic circuitry.  
Adolescents who reported greater negative affect reported higher stress ratings for both 
practice and test blocks, showed greater differences in response times between practice and test 
trials, and were faster on trials overall. They also reported experiencing greater test-related 
anxiety symptoms. However, negative affect was not associated with test accuracy. In the brain, 
greater negative affect was associated with lower activation in regions implicated in stress 
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reactivity (dACC, right anterior insula) and prefrontal regions implicated in regulation (DLPFC, 
MPFC, OFC/VLPFC) during stress. Controlling for gender and negative affect, lower activation 
in dACC and right anterior insula were associated with lower test accuracy. Additionally, lower 
MPFC activation during stress (or greater MPFC activation during Practice > Test) was 
associated with greater perceived test difficulty, over and above negative affect. Moreover, 
greater negative affect was associated with greater activation in bilateral amygdala and bilateral 
hippocampus during periods of low relative to high stress (i.e., Practice > Test). Results from 
Chapter 2/Study 1 indicated that greater activation in regions implicated in emotion/stress 
regulation (e.g., amygdala, hippocampus, VMPFC) during low stress (Practice > Test) were 
associated with greater test-related anxiety, suggesting perhaps that engaging these emotion 
regulation regions during periods of relatively lower stress might reflect poorer stress regulation 
or recovery from stress, which might explain the heightened anxiety symptoms. In the current 
study, that greater daily negative affect was associated with greater activation in these regions 
during Practice > Test as well as greater test-related anxiety might suggest a positive feedback 
loop whereby individuals with greater negative affect might have exaggerated negative 
appraisals of stress, which are paralleled by under-engagement of brain regions that help regulate 
and overcome stress, leading to exacerbated negative appraisals associated with the stressor 
(indicated by higher stress ratings) and increased anxiety symptoms and negative affect. 
Negative affect moderated the associations between IL-6 and perigenual ACC, MPFC, 
and lateral OFC activation during Test > Practice. Among those who reported low negative 
affect, lower levels of IL-6 were associated with greater perigenual ACC and MPFC activation 
during Test > Practice. IL-6 was not associated with perigenual ACC or MPFC activation among 
those who reported average or high negative affect. Controlling for gender, BMI, daily negative 
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affect, and levels of IL-6, perigenual ACC and MPFC activation were not associated with 
behavior or self-report. In contrast, among those who reported high negative affect, higher levels 
of IL-6 were associated with greater lateral OFC activation during Test > Practice. Controlling 
for gender, BMI, daily negative affect, and levels of IL-6, greater OFC activation was associated 
with lower self-rated performance on the test. Research suggests that the perigenual ACC is a 
region that is responsive to social-environmental factors and has implications for stress and 
health depending on whether those factors are risk or resilience factors (Holz, Tost, & Meyer-
Lindenberg, 2020). These findings suggest that greater perigenual ACC and MPFC activation 
during Test > Practice (as opposed to Practice > Test) might be a marker of resiliency in stress, 
which could explain why these individuals evince lower levels of negative affect and IL-6. 
Alternatively, it could be possible that these differences in activation could be explained by 
individuals with low negative affect and IL-6 experiencing fewer daily stressors relative to those 
with high negative affect and IL-6. 
Negative affect also moderated the associations between TNF-a and activation in medial 
prefrontal and orbitofrontal regions during Test > Practice. Among those who reported high 
negative affect, greater levels of TNF-a were associated with greater activation in these medial 
frontal regions during low stress (Practice > Test). This effect was attenuated or in the opposite 
direction among those who reported low negative affect. These findings extend from the negative 
affect findings above to specify that individuals with high daily negative affect and high levels of 
inflammation might evince poorer stress regulation via greater medial frontal activation during 
periods of low stress. These findings also suggest that immune-brain associations may be more 
readily detected during conditions of high negative affect, supporting the notion that negative 
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affect may sensitize the signaling between stress/emotion regulation regions and inflammatory 
markers.  
Stressor reactivity was not associated with behavior or self-report or prefrontal activation 
during Test > Practice. Greater stressor reactivity was associated with greater bilateral amygdala 
and hippocampus activation during Practice > Test, suggesting that adolescents who endorse 
greater negative affect on days that they experience stress may be less likely to regulate 
stress/negative emotions under periods of relatively lower stress. Additionally, stressor reactivity 
moderated associations between IL-6 and MPFC activation during Test > Practice such that 
among those with high reactivity, greater levels of IL-6 was associated with greater MPFC 
activation during Test > Practice (or lower MPFC activation during Practice > Test). Stressor 
reactivity also moderated associations between IFNg and striatal activation (pallidum/amygdala, 
putamen) during Test > Practice. Among those with high stressor reactivity, greater levels of 
IFNg was associated with greater pallidum/amygdala and putamen activation during Test > 
Practice. In contrast, among those with low reactivity, greater levels of IFNg was associated with 
lower pallidum/amygdala and putamen activation during Test > Practice. Controlling for gender, 
BMI, stressor reactivity, and IFNg, greater activation in left pallidum/amygdala was associated 
with greater difference in stress ratings between test and practice blocks, driven by greater stress 
ratings of test blocks among those with greater left pallidum/amygdala activation. These findings 
suggest that the associations between inflammatory markers and frontolimbic response to stress 
depends on individual differences in reactivity to stressors in daily life. That is, those who 
reported greater negative affect in response to stressors in daily life and have higher levels of 
inflammatory markers are more likely to engage frontolimbic circuitry while undergoing a 
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stressor, which was associated with greater stress reactivity (i.e., difference in stress ratings 
between test and practice blocks) to stress, but no differences in performance. 
The current study has several limitations to note. First, the correlational design of the 
study precludes drawing any conclusions regarding the directionality of the relations among the 
daily diary measures, immune markers, and brain function. Based on our hypotheses, the current 
study tested whether daily measures moderated the associations between immune markers and 
brain function and reported findings accordingly, but analyses that test the interaction of daily 
measures and brain function to predict immune markers could have also been conducted and 
different interpretations/conclusions could have possibly been drawn. Second, while we found 
significant effects for the interactions between daily measures and immune markers on brain 
function, the sample size for those analyses were very small, so it remains to be tested whether 
these effects would replicate with larger samples. Moreover, the small sample size could also 
provide insufficient power for us to detect associations between daily stressors and immune 
markers, which previous studies have found. Third, the current sample of adolescents reported 
relatively low levels of daily negative affect (average = 1.751 out of possible 5) and showed 
relatively low levels of circulating immune markers, which limit the generalizability of the 
findings to adolescents who have more adverse experiences. Additionally, the current study’s 
assessment of stressors was limited to demands and arguments; it could be possible that 
adolescents experienced additional stressors that were not captured by our measure (e.g., finding 
out that a loved one is sick, parents losing jobs, etc.). Future studies conducted in larger samples 
that utilize longitudinal or experimental designs with more extensive measures of daily 
experiences, rigorous neuroimaging techniques, and that probe circulating levels of immune 
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markers would be better positioned to delineate the associations between daily experiences and 
the brain-body connection during adolescence. 
Despite these limitations, the current study was the first to investigate the associations 
between daily affective experiences (daily stressors, negative affect, and stressor reactivity), 
peripheral immune markers, and brain function in adolescents. It provided empirical evidence 
that even in a relatively healthy sample of adolescents, variability in daily affective experiences 
and immune markers relate to variability in neural response to stress in corticolimbic circuitry in 
a sample of older adolescents.  
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Chapter 4. Sleep duration and variability moderate the associations between immune 
markers and corticolimbic function during stress 
During adolescence, there is a shift in chronotype such that adolescents prefer a later 
bedtime and waketime (Carskadon et al., 1993) as well as accumulate sleep pressure at a slower 
rate (Jenni, Achermann, & Carskadon, 2005). Coupled with early school start times (Carskadon, 
Wolfson, Acebo, Tzischinsky, & Seifer, 1998), adolescents represent one of the most sleep-
deprived populations – over 60% of U.S. high school students receive less than the 
recommended 7-9 hours of sleep (CDC, 2011; Kann et al., 2014). In addition to negatively 
affecting learning and memory (Walker & Stickgold, 2006), cognition (C. Anderson & Platten, 
2011; Telzer, Fuligni, Lieberman, & Galván, 2013), and decision making (Killgore, Balkin, & 
Wesensten, 2006; Killgore, Kamimori, & Balkin, 2011), individuals who receive insufficient 
sleep are also more likely to experience physical and psychological health problems (Vgontzas et 
al., 2004). For example, across healthy and clinical populations, various forms of poor sleep 
(e.g., experimental partial or total sleep deprivation, naturalistic sleep disturbance, poor sleep 
efficiency) have typically been associated with elevated levels of inflammatory markers such as 
CRP, IL-6, and TNF-a (Irwin, 2015; Irwin et al., 2016). There is also a strong association 
between poor sleep and depressive symptoms (Baglioni et al., 2011). Given the links between 
stress, inflammation, and depressive symptoms reviewed in Chapter 2/Study 1, it is likely that 
stress-related processes are candidate mechanisms by which poor sleep relates to depressive 
symptoms. This area of research has been relatively under-explored, especially in adolescents. 
Emerging evidence suggests that sleep influences the systems that respond to stress (e.g., 
SNS and HPA axis) (Irwin, 2015), which has been shown to regulate immune responses (as 
reviewed in Chapter 2/Study 1). During sleep, blood levels of cortisol, epinephrine, and 
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norepinephrine lower while hormones that subserve cell growth show a steep increase 
(Besedovsky, Lange, & Born, 2012). These processes are disrupted in the context of poor sleep, 
which results in increased SNS and HPA axis activity and have implications for stress 
responding during wake. Compared to well-rested adults, sleep-deprived adults exhibit higher 
baseline cortisol levels and heightened cortisol response to psychosocial stress (Minkel et al., 
2014). Furthermore, the effects of sleep and stress are bidirectional: stressors experienced 
throughout the day and levels of inflammatory cytokines may also influence sleep quality 
(Gordon, Mendes, & Prather, 2017; Raison et al., 2010). Taken together, evidence suggests that 
poor sleep influences immune function and health not only through disruption of processes that 
subserve cell growth and recovery, but also by sensitizing the systems that respond to stress. 
Surprisingly, sleep and stress processes on brain development and immune activity are rarely 
studied together in adolescents. The confluence of changes in HPA function, sleep habits, and 
corticolimbic circuitry that occur during adolescence confers a period of vulnerability to negative 
health outcomes. Burgeoning research examining the links between sleep habits and immune 
markers during adolescence have found that shorter sleep duration was associated with higher 
levels of CRP (Park et al., 2016) and greater likelihood of high risk CRP levels (> 3mg/L) (Hall, 
Lee, & Matthews, 2015). Greater variability in sleep duration was also associated with higher 
levels of CRP (Park et al., 2016). In relation to the upstream molecular immune processes, 
shorter sleep duration was associated with greater gene expression of pro-inflammatory proteins, 
increased signaling of pro-inflammatory transcription factor NF-kB, downregulation of antiviral 
gene expression, and decreased signaling of interferon response factors in adolescents (Chiang et 
al., 2019a). Moreover, shorter sleep duration strengthened the associations between daily stress 
and NF-kB activity. That is, greater daily stress was more strongly associated with greater 
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inflammatory NF-kB activity among adolescents with shorter sleep duration (Chiang et al., 
2019a). These findings suggest that poor sleep may sensitize the brain to the psychological and 
physiological effects of stress, including the effects of inflammation, which may further 
potentiate stress sensitivity and responses. However, the effects of sleep and inflammation on the 
developing brain’s response to stress are unknown.  
The current study examined whether sleep duration and variability relate to levels of 
peripheral immune markers and the brain’s response to stress in adolescents. I hypothesized that 
adolescents who reported shorter sleep duration and greater variability in sleep duration would 
exhibit higher levels of pro-inflammatory markers and heightened neural response to stress. The 
current study also explored whether sleep habits moderate the association between inflammation 
and neural responses to stress. 
Methods 
Participants 
Self-report questionnaires, daily diary, and neuroimaging data were collected from 40 
adolescents (14.03-15.99 years, M = 15.076, SD = 0.646, 17 females) who participated in a 
larger study conducted by Drs. Galvan, Fuligni, and Eisenberger (NSF BSC 1551952). 
Participants were recruited using flyers posted on university campus, in local child and 
adolescent-friendly locations, on community websites (e.g., Craigslist), and flyer distributions at 
local high schools. Inclusion criteria required all participants be right-handed, free from metal 
objects in the body, speak fluent English, be in the appropriate age range, and have no previously 
diagnosed psychiatric, neurological, or developmental disorders. Parents of adolescent 
participants provided written consent and adolescents provided assent in accordance with the 
University of California, Los Angeles (UCLA) Institutional Review Board. Participants were 
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also provided the opportunity to consent to an optional blood draw. All participants were 
compensated for their participation.  
Of the 40 participants, one participant was excluded from neuroimaging analyses due to a 
neuroanatomical abnormality and two participants were excluded for excessive motion across 
both runs of the task. Of the remaining 37 (18 females) participants with usable neuroimaging 
data, 23 (62%; 9 females) participated in the blood draw. Analyses were conducted with the 
maximum number of subjects for each analysis. 
Procedure 
 Participants completed two visits at UCLA. During the first visit, after providing consent, 
participants completed questionnaires about demographic information and depressive symptoms 
and were trained on how to complete the daily diary measures. For 7 days after the first visit, 
participants received a text message each evening with a URL to an online survey asking about 
their day that they completed. After 7 days (but within two weeks), participants returned to 
UCLA to complete their second visit. Participants who consented to the blood draw had their 
blood drawn by a certified phlebotomist at the clinical lab in the Peter Morton Medical Building 
at UCLA. After the blood draw, participants completed a brain scan while performing the fMRI 
stressor task at the Center for Cognitive Neuroscience (CCN) at UCLA. Participants who did not 
consent to the blood draw only completed the brain scan portion of the study. Participants’ height 
and weight were measured to calculate body mass index (BMI). BMI ranged from 14.337 to 
45.154 (M = 23.298, SD = 6.299). After the brain scan, participants completed additional 
questionnaires about their experiences regarding the stressor task, were debriefed about the goals 
of the study, and received compensation. 
Measures 
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Sleep Duration. Each night, participants were asked to report how much sleep they 
received the night before. Daily sleep duration was averaged across the 7 days to assess 
participants’ average nightly sleep duration. Average weekly sleep duration ranged from 259.285 
minutes to 585.857 minutes (M = 467.452 minutes, SD = 60.479). 
Sleep Duration Variability. For each participant, standard deviation in self-reported sleep 
duration across the week was calculated to assess variability in sleep duration. Variability ranged 
from 23.604 minutes to 292.391 minutes (M = 85.139 minutes, SD = 53.593). 
Immunological Measures 
A detailed description of blood sample collection, processing, and immunological assays 
are reported in the Methods: Immunological Measures section of Chapter 2/Study 1. 
fMRI 
A detailed description of the fMRI Stressor Task, Data Acquisition, Data Preprocessing, 
and Level 1 analyses are previously reported in the Methods: fMRI section of Chapter 2/Study 1.  
Analytic Plan 
 All reported analyses covaried for gender. All analyses consisting of sleep variability 
additionally covaried for average sleep duration. All analyses consisting of peripheral immune 
markers covaried for gender and body mass index (BMI).  
 Regression analyses were used to relate participants’ average sleep duration and 
variability in sleep duration to levels of peripheral immune markers. 
Behavioral Analysis of Stressor Task. Repeated-measures ANCOVAs and regression 
analyses were conducted to determine whether stress ratings, behavior on stressor task, 
participants’ responses to the test-related STAI, and post-task questionnaire differed by average 
sleep duration and sleep variability. 
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fMRI Data Analysis. A detailed description of level 1 analyses is previously reported in 
Methods: Analytic Plan section of Chapter 2/Study 1. Analyses focused on the contrast between 
test blocks and practice blocks (Test > Practice, Practice > Test). A fixed effects voxel-wise 
analysis combined each of the two runs at the second level. Regression analyses were conducted 
at the group level using the FMRIB local analysis of mixed effects (FLAME1) module in FSL 
with mean-centered regressors of interest (e.g., sleep duration, sleep variability) entered in each 
respective model in whole brain analyses. Z (Gaussianized T) statistic images were thresholded 
at Z > 2.3 by a corrected cluster significant threshold of p < .05 using Gaussian Random Field 
theory and corrected for family-wise errors. Anatomical localization within each cluster were 
obtained by searching within maximum likelihood regions from the FSL Harvard-Oxford 
probabilistic atlas. 
Average sleep duration and sleep duration variability were entered as mean-centered 
regressors of interest in separate GLMs for whole-brain fMRI analyses to assess their 
associations with neural response to stress. Moderation analyses for each sleep measure and each 
immune marker were conducted at the whole-brain level to assess whether average sleep 
duration and/or variability moderated associations between immune markers and neural response 
to stress. 
ROI Analyses. In addition to whole-brain analyses, ROI analyses were also conducted in 
regions previously implicated in stress reactivity and regulation (e.g., dACC, left and right 
anterior insula, left and right amygdala, and left and right hippocampus). A detailed description 
of the ROIs is previously reported in Methods: Analytic Plan section of Chapter 2/Study 1. 
Results 
Sleep duration and inflammation 
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 Controlling for gender and BMI, average sleep duration across the week was not 
associated with levels of IFNg g (B = -0.00015, SE = .002, t(18) = -0.097, p = .924), IL-10 (B = 
.001, SE = .001, t(18) = 1.00, p = .331), IL-6 (B = -.001, SE = .002, t(18) = -.310, p = .760), IL-8 
(B = -.004, SE = .002, t(18) = -1.720, p = .103), or TNF-a (B = -.000194, SE = .00057, t(18) = -
.338, p = .739). 
Sleep duration variability and inflammation 
 Controlling for gender, BMI, and average sleep duration, sleep duration variability was 
marginally negatively associated with IL-10 (B = -.002, SE = .001, t(17) = -2.023, p = .059). 
Sleep duration variability was not associated with levels of IFNg (B = -.001, SE = .002, t(17) = -
.783, p = .444), IL-6 (B = -.001, SE = .002, t(17) = -.330, p = .746), IL-8 (B = -.001, SE = .002, 
t(17) = -.301, p = .767), or TNF-a (B = -.00029, SE = .001, t(17) = -.440, p = .666). 
Behavior on fMRI Stressor Task 
Stress ratings. Main effects of stress ratings were reported in Chapter 2/Study 1. 
Controlling for gender, differences in stress ratings did not differ by sleep duration (F(1, 32) = 
.287, p = .596) or sleep variability (F(1, 31) = 3.299, p = .079). 
Response time. Main effects of response time were reported in Chapter 2/Study 1. 
Controlling for gender, differences in response time did not differ by sleep duration (F(1, 32) = 
.607, p = .441) or sleep duration variability (F(1, 31) = 1.218, p = .278). 
Test Accuracy. Controlling for gender, test accuracy did not significantly differ by sleep 
duration (B = .000273, SE = .001, t(32) = .471, p = .641) or sleep duration variability (B = -
0.001, SE = .001, t(31) = -0.829, p = .414). 
Evaluation of fMRI Stressor Task 
 92 
Anxiety. Controlling for gender, test-related anxiety did not differ by sleep duration (B = 
.001, SE = .015, t(32) = .036, p = .972) or sleep variability (B = -.030, SE = .016, t(31) = -1.825, 
p = .078). 
Perceived Task Difficulty. Controlling for gender, perceived task difficulty did not differ 
by sleep duration (B = -0.002, SE = .002, t(32) = -1.047, p = .303) or sleep variability (B = -
.0001, SE = .003, t(31) = -.070, p = .994). 
Self-Rated Performance. Greater sleep variability was associated with better self-rated 
performance, controlling for gender and average sleep duration (B = .010, SE = .004, t(31) = 
2.469, p = .019). Self-rated performance did not differ by sleep duration (B = .004, SE = .004, 
t(32) = 1.052, p = .301), controlling for gender. 
Main effects of fMRI Stressor Task 
 Detailed analyses of the main effects of fMRI Stressor Task were previously reported in 
Chapter 2/Study 1. Briefly, on average, participants engaged DLPFC, ACC, anterior insula, and 
OFC regions more during test blocks compared to practice blocks. Greater bilateral anterior 
insula (ROIs) activation during Test > Practice were associated with greater test accuracy. In 
contrast, participants engaged VMPFC, amygdala, hippocampus, and posterior cingulate regions 
more during practice blocks compared to test blocks. Greater bilateral amygdala and 
hippocampal activation (ROIs) during Practice > Test were marginally associated with greater 
test-related anxiety.  
Sleep duration and neural response to stress 
 Whole-brain analyses revealed that, controlling for gender, average sleep duration was 
not associated with activation during Test > Practice. ROI analyses revealed that, controlling for 
gender, average sleep duration was not significantly associated with dACC (B < .001, SE < .001, 
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t(32) = -.119, p = .906), bilateral anterior insula (left: B < .001, SE < .001, t(32) = -.386, p = 
.702; right: B < .001, SE < .001, t(32) = -.369, p = .715), bilateral amygdala (left: B < .001, SE < 
.001, t(32) = -.016, p = .987; right: B < .001, SE < .001, t(32) = .172, p = .865), or bilateral 
hippocampus (left: B < .001, SE < .001, t(32) = -.238, p = .813; right: B < .001, SE < .001, t(32) 
= -.332, p = .742) activation during Test > Practice. 
Sleep variability and neural response to stress 
 Whole-brain analyses revealed that, controlling for gender and average sleep duration, 
sleep variability was not associated with activation during Test > Practice. Controlling for gender 
and average sleep duration, ROI analyses revealed that sleep variability was not significantly 
associated with dACC (B < .001, SE < .001, t(31) = -0.501, p = .620), bilateral anterior insula 
(left: B < .001, SE <.001, t(31) = -1.550, p = .131; right: B < .001, SE < .001, t(31) = -1.484, p = 
.148), bilateral amygdala (left: B < .001, SE < .001, t(31) = .441, p = .662; right: B < .001, SE < 
.001, t(31) = .743, p = .463), or bilateral hippocampus (left: B < .001, SE < .001, t(31) = .600, p 
= .553; right: B < .001, SE < .001, t(31) = .371, p = .714) activation during Test > Practice. 
Immune markers and neural response to stress 
 Detailed analyses of the associations between immune markers and neural response to 
stress were previously reported in Chapter 2/Study 1. Briefly, levels of immune markers were not 
significantly associated with regions in corticolimbic circuitry during Test > Practice.  
Interactions between sleep variables and peripheral immune markers on neural response 
to stress 
 Sleep duration. Whole-brain analyses testing for interactions between average sleep 
duration and immune markers on neural response to stress (Test > Practice), controlling for 
gender and BMI, revealed significant interactions between sleep duration and TNF-a in right 
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amygdala, right subgenual ACC, left MPFC and frontal pole, right temporal pole, left posterior 
cingulate, left precuneous and occipital cortex, right angular gyrus, and bilateral supramarginal 
gyrus during Test > Practice (Table 4.1; Figure 4.1). Parameter estimates (5mm spheres around 
peak activation) from right amygdala, right subgenual ACC, and left MPFC were extracted to 
probe the nature of the interaction. Follow up analyses revealed that among individuals who 
reported short sleep duration (1 SD below mean = 386.879 minutes), greater levels of TNF-a 
were associated with lower activation in right amygdala, right subgenual ACC, and left MPFC 
during Test > Practice (or greater activation during Practice > Test) (amygdala: B = -.2757, SE = 
.0724, t(16) = -3.8058, p = .0016; subgenual ACC: B = -.7072, SE = .2443, t(16) = -2.8952, p = 
.0105; MPFC: B = -.2954, SE = .1215, t(16) = -2.4316, p = .0272). Additionally, among those 
who reported long sleep duration (1 SD above mean = 530.660), greater levels of TNF-a were 
associated with greater amygdala and MPFC activation during Test > Practice (or lower 
activation during Practice > Test) (amygdala: B = .2441, SE = .0772, t(16) = 3.1624, p = .006; 
MPFC: B = .4134, SE = .1294, t(16) = 3.1939, p = .0056). In contrast, levels of TNF-a were not 
associated with subgenual ACC activation during Test > Practice among those who reported long 
sleep duration (B = .4465, SE = .2603, t(16) = 1.7151, p = .1056). Among those who reported 
average sleep duration, levels of TNF-a were not associated with amygdala, subgenual ACC, or 
MPFC activation during Test > Practice (amygdala: B = -.0158, SE = .0459, t(16) = -.3437, p = 
.7356; subgenual ACC: B = -.1304, SE = .1549, t(16) = -.8417, p = .4124; MPFC: B = .0590, SE 
= .0770, t(16) = .7663, p = .4546) (Figure 4.1). Controlling for gender, BMI, sleep duration, and 
levels of TNF-a, activation in these regions were not associated with behavior or task evaluation.  
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Figure 4.1. Sleep duration moderated the associations between TNF-a and activation in 
amygdala, subgenual ACC, and MPFC for Test > Practice, cluster-corrected at Z > 2.3, p < .05. 
 
Analyses also revealed significant interactions between sleep duration and IL-8 in right 
caudate and putamen, left precuneus, and right occipital pole during Test > Practice (Table 4.1; 
Figure 4.2). Parameter estimates (5mm spheres around peak activation) from right caudate and 
putamen were extracted to probe the nature of the interaction. Follow up analyses revealed that 
among individuals who reported short sleep duration, greater levels of IL-8 were associated with 
lower caudate and putamen activation during Test > Practice (caudate: B = -.0600, SE = .0180, 
t(16) = -3.3285, p = .0043; putamen: B = -.0673, SE = .0287, t(16) = -2.3435, p = .0323). 
Additionally, among individuals who reported long sleep duration, greater levels of IL-8 were 
associated with greater caudate activation during Test > Practice (B - .0606, SE = .0156, t(16) = 
3.8753, p = .0013). In contrast, levels of IL-8 were not significantly associated with putamen 
activation during Test > Practice among those who reported long sleep duration (B = .0416, SE = 
.0249, t(16) = 1.6707, p = .1142). Among individuals who reported average sleep duration, levels 
of IL-8 were not associated with caudate or putamen activation during Test > Practice (caudate: 
B = .0003, SE = .0095, t(16) = .0309, p = .9758; putamen: B = -.0128, SE = .0152, t(16) = -
.8474, p = .4092) (Figure 4.2). Controlling for gender, BMI, sleep duration, and levels of IL-8, 
activation in these regions were not associated with behavior or task evaluation. 
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Figure 4.2. Sleep duration moderated the associations between IL-8 and activation in right 
caudate and putamen for Test > Practice, cluster-corrected at Z > 2.3, p < .05. 
 
 Sleep duration also moderated the associations between IL-6 and left occipital activation; 
and between IL-10 and bilateral precentral gyrus activation during Test > Practice (Table 4.1). 
 Sleep variability. Whole-brain analyses testing for interactions between sleep variability 
and immune markers on neural response to stress (Test > Practice), controlling for gender, BMI, 
and average sleep duration, revealed significant interactions between IFNg and left inferior 
frontal gyrus (pars triangularis and opercularis) and left frontal pole activation during Test > 
Practice (Table 4.1, Figure 4.3). Parameter estimates (5mm spheres around peak activation) from 
left IFG (pars triangularis and opercularis) and frontal pole were extracted to probe the nature of 
the interaction. Follow up analyses revealed that among individuals who exhibit low sleep 
variability (1 SD below mean = 34.4094), greater levels of IFNg were associated with greater 
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activation in IFG (triangularis) during Test > Practice (B = .1468, SE = .0516, t(15) = 2.8430, p 
= .0123). In contrast, levels of IFNg were not associated with activation in left IFG (opercularis) 
and frontal pole among those with low sleep variability (IFG opercularis: B = .0498, SE = .0296, 
t(15) = 1.6794, p = .1138; frontal pole: B = .0626, SE = .0383, t(15) = 1.6340, p = .1231). 
Among those who exhibit high sleep variability (1 SD above mean = 158.2830), greater levels of 
IFNg were associated with lower activation in IFG (triangularis and opercularis) and left frontal 
pole (IFG triangularis: B = -.1415, SE = .0591, t(15) = -2.3925, p = .0303; IFG opercularis: B = -
.1759, SE = .0339, t(15) = -5.1809, p = .001; frontal pole: B = -.1342, SE = .0439, t(15) = -
3.0574, p = .008). Additionally, among those who exhibit average sleep variability, greater levels 
of IFNg were associated with lower levels of IFG opercularis activation during Test > Practice (B 
= -.0630, SE = .0169, t(15) = -3.7386, p = .002). In contrast, levels of IFNg were not associated 
with left IFG triangularis or frontal pole activation for those who exhibit average sleep variability 
(B = .0026, SE = .0294, t(15) = .0898, p = .9296; frontal pole: B = -.0358, SE = .0218, t(15) = -
1.6414, p = .1215) (Figure 4.3). Controlling for gender, BMI, average sleep duration, sleep 
variability, and levels of IFNg, greater left frontal pole activation during Test > Practice was 
associated with better accuracy (B = 1.891, SE = .880, t(15) = 2.149, p = .048. Greater left IFG 
triangularis and frontal pole activation during Test > Practice were associated with lower 
perceived test difficulty (IFG triangularis: B = -6.516, SE = 2.401, t(15) = -2.713, p = .016; 
frontal pole: B = -9.093, SE = 3.329, t(15) = -2.731, p = .015) (Figure 4.4). 
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Figure 4.3. Sleep variability moderated the associations between IFNg and activation in left IFG 
and frontal pole for Test > Practice, cluster-corrected at Z > 2.3, p < .05. 
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Figure 4.4. Greater activation in left frontal pole during Test > Practice was associated with 
greater accuracy and lower perceived test difficulty. Greater activation in left IFG triangularis 
during Test > Practice was associated with lower perceived test difficulty. 
 
 Sleep variability also moderated the associations between IL-6 and supramarginal gyrus, 
precentral gyrus, and postcentral gyrus activation during Test > Practice (Table 4.1). 
 
 Immune 
Marker 
Hemisphere Region x y z Z-max 
 
Test > Practice 
        
Sleep Duration IL-6 L Occipital pole -16 -104 -10 4.60 
        
 TNF-a R Amygdala 28 2 -26 3.95 
  L Frontal Pole -2 60 22 3.83 
  L MPFC -8 60 2 3.65 
  R Subgenual ACC 10 26 -18 3.69 
  R Temporal pole 56 12 -28 3.77 
  L Posterior cingulate -2 -42 30 3.64 
  L Precuneus -2 -60 32 3.35 
  R Angular gyrus 56 -52 48 3.51 
  L/R Supramarginal gyrus -64 -44 30 4.24 
    60 -40 48 3.49 
  L Lateral occipital cortex -44 -64 44 3.46 
        
 IL-8 R Caudate 10 6 18 3.07 
  R Putamen 18 12 -6 2.91 
  L Precuneus -24 -50 6 3.47 
  R Occipital pole 28 -98 12 4.16 
        
 IL-10 L/R Precentral gyrus -58 -2 28 3.79 
    62 6 24 3.01 
        
        
Sleep Variability IL-6 L Postcentral gyrus -54 -22 42 3.53 
  L Precentral gyrus -54 -6 36 2.96 
  L Supramarginal gyrus -36 -38 34 3.29 
        
 IFNg L IFG, pars triangularis -52 36 10 3.23 
  L IFG, pars opercularis -48 18 18 3.05 
  L Frontal pole -44 38 10 2.97 
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Table 4.1. Significant interactions between sleep measures (average duration, duration 
variability) and peripheral immune markers on neural activation during Test > Practice, cluster 
corrected at Z > 2.3, p < .05. Note: x, y, and z refer to MNI coordinates, Z-max refers to peak 
level of activation intensity. L = left, R = right. 
 
Discussion 
The current study investigated whether adolescents’ sleep patterns (average sleep 
duration and variability in sleep duration) related to peripheral immune markers and neural 
response to stress. Using a daily diary approach, adolescents self-reported their sleep time for the 
previous night each night for seven days. Average sleep duration was calculated by averaging 
sleep time reported across the week. Sleep duration variability was determined by calculating the 
standard deviation of sleep duration from each subject’s average sleep duration. Results revealed 
that average sleep duration was not significantly associated with immune markers. However, 
greater sleep duration variability was marginally associated with lower levels of IL-10, 
controlling for gender, BMI, and average sleep duration. While these findings did not replicate 
previous research in regard to greater sleep variability being associated with greater 
inflammation in adolescents (e.g., Park et al., 2016), these findings complemented previous 
research by demonstrating that sleep variability may also have effects on anti-inflammatory 
processes. 
Sleep duration and sleep variability were not significantly associated with behavior on the 
stressor task or evaluation of the stressor. Sleep duration and sleep variability were also not 
significantly associated with neural response to stress (Test > Practice). 
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Interestingly, sleep duration moderated the associations between inflammatory markers 
(TNF-a and IL-8) and neural response to stress in corticolimbic circuitry. Specifically, among 
adolescents who reported short sleep duration (about 386 minutes on average), greater levels of 
TNF-a were associated with greater activation in stress/emotion regulation regions (amygdala, 
subgenual ACC, MPFC) during periods of low stress (Practice > Test). In contrast, among 
adolescents who reported long sleep duration (about 530 minutes), greater levels of TNF-a were 
associated with lower activation in amygdala and MPFC during low stress (Practice > Test). In 
relation to IL-8, greater levels of IL-8 were associated with lower caudate and putamen 
activation during Test > Practice among adolescents who reported short sleep. Based on findings 
from Chapter 2/Study 1 and Chapter 3/Study 2, greater activation in these emotion regulation 
regions (e.g., amygdala, MPFC) during periods of lower stress (i.e., Practice > Test) were 
associated with greater self-reported anxiety and negative affect, suggesting possible protracted 
recovery from stress or amplified stress anticipation during periods of low stress. The current 
findings suggest that short/insufficient sleep might exacerbate the associations between 
inflammation and heightened activation in emotion reactivity/regulation regions during periods 
of relatively lower stress, which has implications for increased negative affect and potentiated 
stress reactivity. On the other hand, the current findings also suggest that long/sufficient sleep 
might buffer the effects that inflammation has on stress-related circuitry. 
Sleep variability moderated associations between IFNg and neural response to stress in 
regions related to cognitive control (left IFG/DLPFC), controlling for gender, BMI, and sleep 
duration. Specifically, among adolescents who exhibited high sleep variability (deviating about 
158 minutes from average sleep duration across the week), greater levels of IFNg were 
associated with lower activation in left IFG/DLPFC regions during Test > Practice. In contrast, 
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among adolescents who exhibited low sleep variability (deviating about 34 minutes from average 
sleep duration across the week), greater levels of IFNg were associated with greater activation in 
left IFG/DLPFC during Test > Practice. Additionally, over and above levels of IFNg and sleep 
variability, greater activation in left IFG/DLPFC regions during stress was associated with better 
accuracy and lower perceived test difficulty. These findings suggest that 1) engagement of lateral 
prefrontal regions during stress may be conducive to better performance/resilience under stress, 
consistent with previous work demonstrating that engagement of lateral prefrontal regions under 
stress facilitates better cognitive control and risky decision-making (Rahdar & Galván, 2014; Uy 
& Galván, 2017); and 2) that adolescents with lower sleep variability and higher levels of IFNg 
may be better able to engage lateral prefrontal regions during stress that helps them overcome the 
stressor. 
The immune system is influenced by both sleep and circadian processes. Research that 
characterized profiles of systemic and cellular inflammation over the course of a regular sleep-
wake cycle relative to 24-hour of continuous wakefulness found that sleep increases levels of IL-
6 and production of TNF-a, suggesting the involvement of these cytokines in the regulation of 
sleep-wake behavior. Sleep deprivation delays the nocturnal increase in IL-6 levels, attenuates 
nocturnal production of TNF-a, and shifts the pattern of IL-6 secretion from night-time to 
daytime, leading to an over-secretion of IL-6 during the day and excessive inflammation 
(Dimitrov, Besedovsky, Born, & Lange, 2015; Vgontzas et al., 1999).  
In regard to adaptive immunity, circulating T and B cells peak early in the evening and 
migrate from circulation to lymphoid organs where they may come into contact with antigens, 
such as viruses. Sleep promotes the activation of T cells through their increased production of 
IL-2 and IFNg, which induces Th1 cell-type adaptive immune response and increase immune 
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defense (Lange, Dimitrov, & Born, 2010). Sleep loss not only impacts the ability of these cells to 
be at the right place at the right time, but may also impair T cell functioning, which includes 
diminished antigen-specific response by helper T cells and declines in production of cytokines 
essential to T-cell maturation (Bollinger et al., 2009). Sleep disturbance also induces a shift away 
from Th1 cell-type adaptive immune response towards Th2 cell-type cytokine activity, leading to 
increased susceptibility to viral infections (Dimitrov, Lange, Tieken, Fehm, & Born, 2004; 
Lange, Dimitrov, Fehm, & Born, 2006). Indeed, short habitual sleep was associated with 
increased risk for the development of pneumonia (Patel et al., 2012) and higher incidences of 
reported respiratory infections compared to sufficient sleep duration (Prather & Leung, 2016). 
Sleep stages also regulate inflammatory activity. Sleep disturbances have been found to 
decrease the duration of slow-wave sleep (SWS), a component of non-REM (NREM) sleep, and 
increase the duration of REM sleep (Irwin, 2015). During SWS, cortisol is at its lowest level, 
which promotes antiviral immune responses, as indicated by greater Th1/Th2 ratio (Dimitrov et 
al., 2004). Sympathetic nervous system (SNS) activity also decreases during NREM sleep. Sleep 
deprivation prevents this NREM/SWS-related decrease in SNS activity, leading to overall 
increased SNS activity during the night (Irwin, Thonpson, Miller, Gillin, & Ziegler, 1999) and 
disrupted antiviral immune response (Lange et al., 2010). Additionally, longer time spent in 
REM sleep has been correlated with greater morning levels of IL-6 as well as greater activation 
of the SNS. Thus, sleep disturbance results in persistent activation of the HPA axis, which can 
induce glucocorticoid resistance of immune cells (Abell, Shipley, Ferrie, Kivimäki, & Kumari, 
2016; Castro-Diehl et al., 2015), decrease antiviral immune response, and increase SNS activity.  
In addition to the effects of sleep disturbance on immune function, inflammatory and 
anti-viral signals could also signal the brain to induce sickness behaviors to aid recovery from 
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infection, including fatigue, sleepiness, negative mood, and hypersensitivity to pain. In relation 
to sleep, researchers have discovered that IL-1 and TNF cytokines play a role in homeostatic 
regulation of NREM sleep in animals. For example, blocking the actions of IL-1 and TNF led to 
a reduction in physiological NREM sleep duration and NREM sleep rebound after sleep 
deprivation (Krueger & Majde, 1995; Opp, 2005). Moreover, the production of IL-1 and TNF is 
enhanced after sleep deprivation, which correlates with greater amounts of recovery sleep in 
animals (Lue et al., 1988). In humans, low doses of endotoxin induce inflammatory activity and 
result in enhanced NREM and SWS sleep (Krueger, 2008; Mullington et al., 2000). While not as 
well-studied as IL-1 or TNF, research suggests that other pro-inflammatory cytokines (e.g., IFNg 
and IL-6) may also have NREM sleep-promoting actions (Hogan, Morrow, Smith, & Opp, 2003; 
Kubota, Majde, Brown, & Krueger, 2001). Together, these findings suggest that inflammatory 
cytokines drive the propensity to sleep. 
The current findings – that higher levels of TNF-a were associated with a pattern of brain 
activity during stress that was related to increased negative affect and anxiety among adolescents 
who report shorter sleep duration – are consistent with the role of TNF-a in regulating sleep and 
other sickness behaviors. That is, in the context of insufficient sleep, greater levels of TNF-a 
may modulate brain function in attempts to increase behaviors/states (e.g., negative affect) that 
would promote sleep. Unfortunately, the current study did not assess levels of sleepiness or 
attentiveness during the laboratory visit. The effects of TNF-a on brain function may not have 
been observed for adolescents with high sleep variability because of the likely increase in 
rebound sleep after acute sleep restriction. Indeed, studies found that plasma levels of TNF were 
mostly unchanged during or on the day after acute sleep deprivation/restriction in humans 
(Haack, Schuld, Kraus, & Pollmächer, 2001; Irwin, Olmstead, Valladares, Breen, & Ehlers, 
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2009; Ruiz et al., 2010; Shearer et al., 2001), but were increased after one week of sleep 
restriction (Vgontzas et al., 2004), suggesting that prolonged sleep deprivation or restriction may 
be required to detect sleep-related changes in TNF-a.  
In regard to the IFNg and sleep variability findings, it could be possible that higher levels 
of IFNg may serve different functions among individuals with higher relative to lower sleep 
variability, reflected through divergent effects on the brain’s cognitive system and associated 
outcomes. Higher levels of IFNg in the context of high sleep variability may reflect a 
homeostatic drive by IFNg to induce sleep and other energy-conserving practices, such as 
lowered cognitive function, whereas higher levels of IFNg in the context of low sleep variability 
may reflect immune defense functioning, which engenders the organism to actively engage in 
stress/challenge. Although average sleep duration and sleep variability may be driven by similar 
physiological processes, sleep variability may additionally capture day-to-day situational 
changes in affect, work schedules, stress, or illness symptomatology that may be obscured when 
only examining mean sleep duration (Slavish, Taylor, & Lichstein, 2019).  
The current study has several limitations to note. First, the correlational design of the 
study precludes drawing any conclusions about the directionality of the relations among the sleep 
measures, immune markers, and brain function. Second, while we found significant effects for 
the interactions between sleep habits and immune markers on brain function, the sample size for 
those analyses were very small, so it remains to be tested whether these effects would replicate in 
larger samples. Relatedly, the small sample size could have provided insufficient power to detect 
significant associations between sleep habits and immune markers, which previous studies have 
found. Third, sleep duration and sleep variability were determined via self-report from the 
adolescents and also at the end of the day rather than when they wake up that day, which may not 
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be as accurate as more objective measures of daily sleep such as actigraphy. Additionally, sleep 
duration was measured for only one week and it was assumed that this one week captured an 
average week in the adolescents’ lives. However, it could be possible that sleep behavior during 
the measured week may not represent some adolescents’ average week (e.g., adolescents could 
be on break from school, traveling, having a particularly challenging week, etc.). Unfortunately, 
typicality of the week was not assessed. 
Despite limitations, the current study makes novel contributions to the associations 
between self-reported sleep habits, peripheral immune markers, and brain function in 
adolescents. It provided empirical evidence that even in a relatively healthy sample of 
adolescents, variability in sleep patterns and immune markers relate to variability in neural 
response to stress in corticolimbic circuitry in a sample of older adolescents.  
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Chapter 5. General Discussion 
The goal of the current dissertation was to investigate whether and how peripheral 
immune markers modulate neural function of stress circuitry during adolescence, and whether 
these immune-brain associations are predicted or moderated by daily affective experiences and 
sleep habits.  The ultimate goal is to uncover implications for understanding how these processes 
relate to mental health and well-being. During adolescence, there is a significant increase in the 
onset and prevalence of depression (Mojtabai et al., 2016; Substance Abuse and Mental Health 
Services Administration, 2017). Substantial changes in neurobiological and neuroendocrine 
systems, in addition to changes in adolescents’ social environment and lifestyles (e.g., sleep 
habits), have been posited to underlie the onset and potentiation of depression. Research in 
animal and human adult work has implicated the immune system in psychological functioning 
and well-being through modulation of affective neural circuitry and stress systems (Kraynak et 
al., 2018). These systems are more sensitive and therefore more vulnerable to environmental 
influences during adolescence than in adulthood (e.g., Brenhouse & Schwarz, 2016; Crone & 
Dahl, 2012; Dahl & Gunnar, 2009; Romeo, 2017). Research in adolescents suggests that the link 
between immunity and depressive symptoms is not only present in youth who have depression 
(Gabbay et al., 2009; Henje Blom et al., 2012; Miller & Cole, 2012; Pandey et al., 2012), but 
also in those who are otherwise healthy (Chiang et al., 2017; Chiang et al., 2019b; Guan et al., 
2016). Indeed, among healthy adolescents, variability in psychosocial factors (e.g., interpersonal 
stress, poor sleep) are related to immune functioning (Chiang et al., 2019a; Fuligni et al., 2009; 
Park et al., 2016). Health status during adolescence tends to predict health status later in 
adulthood. Therefore, understanding how experiences during adolescence relate to immune 
functioning is important to provide novel perspectives for interventions. Elucidating the 
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neurobiological correlates of immune functioning during adolescence would advance the field 
forward in determining whether there might be distinct neuroimmune effects during this 
formative developmental period. 
The research presented provides novel evidence that peripheral immune markers may 
play a role in corticolimbic circuitry function during stress in an otherwise healthy sample of 
adolescents; however, the findings reveal a fairly nuanced understanding of the relations between 
peripheral immune markers and brain function during adolescence.  
By combining daily diary methods with functional neuroimaging and multiplex cytokine 
assays of venipuncture samples, findings suggest that daily affective experiences and sleep habits 
are relevant moderators of the associations between certain peripheral immune markers and 
neural response to stress. Specifically, among adolescents who reported experiencing greater 
negative affect in their daily lives, higher levels of pro-inflammatory TNF-a were associated 
with greater medial prefrontal (MPFC) activation during periods of low relative to high stress 
(i.e., Practice > Test), which was found to be associated with greater negative affect, perceived 
stressor difficulty, higher stress ratings, and greater test-related anxiety symptoms. This effect 
was reduced among those who reported lower negative affect in their daily lives. A similar 
pattern of results was also observed for sleep duration and levels of TNF-a in regions implicated 
in emotion/stress regulation (MPFC, subgenual ACC, amygdala) such that higher levels of TNF-
a were associated with greater activation in these regions during periods of low relative to high 
stress among adolescents who reported short/insufficient sleep duration whereas these 
associations were attenuated among those who reported sufficient sleep duration. These findings 
suggest that perhaps engaging these emotion regulation regions during periods of relatively 
lower stress might reflect protracted regulation or recovery from stress, which could potentiate a 
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positive feedback loop whereby high negative affect (and inflammation) could lead to 
exaggerated negative appraisals of stress, which could lead to a neural response pattern that may 
increase stress appraisal, negative affect, and anxiety symptoms. Levels of TNF-a are regulated 
by both stress and sleep processes whereby greater stress and sleep disturbance lead to greater 
levels of circulating levels of TNF-a. In turn, one of the roles of TNF-a is to induce sickness 
behaviors/states, including negative affect and sleepiness, to promote recovery from physical or 
psychological stress by acting on relevant systems in the central nervous system (Besedovsky, 
Lange, & Haack, 2019; Irwin, 2019; Prather, 2019). While speculative, the current findings 
suggest that higher levels of TNF-a in the context of short/insufficient sleep may reflect a 
homeostatic drive to induce sickness behaviors that would promote sleep via modulation of the 
stress/emotion regulation circuitry.  
Another notable finding from the current research is that variability in sleep duration 
interacted with IFNg to predict activation of lateral prefrontal regions during periods of high 
relative to low stress (i.e., Test > Practice). In particular, among adolescents who exhibited low 
sleep duration variability, higher levels of IFNg were associated with greater lateral prefrontal 
activation during periods of high relative to low stress, which was associated with better 
performance on the stressor and lower perceived stressor difficulty. In contrast, the opposite 
pattern was observed among adolescents who exhibited high sleep duration variability – that is, 
higher levels of IFNg were associated with greater lateral prefrontal activation during low 
relative to high stress, which was associated with poorer performance on the stressor and greater 
perceived stressor difficulty. Similar to TNF-a, stress and sleep disturbances also alter levels of 
IFNg and its corresponding role in antiviral defense (Besedovsky et al., 2019; Irwin, 2019). The 
current findings suggest that whereas TNF-a appears to play a role in modulating stress/emotion 
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regulation circuitry, IFNg might play a role in modulating cognitive/executive function circuitry. 
It is speculated that higher levels of IFNg may serve different functions among individuals with 
higher relative to lower sleep variability, as reflected through divergent effects on the brain’s 
cognitive system and associated outcomes.  
Together, these findings support the notion that peripheral immune markers may promote 
sickness-type behaviors/states (e.g., negative affect, increased anxiety, poorer cognition) through 
modifying the respective neurocircuitry in response to stress/challenge. The interactive effects of 
these immune-brain associations by negative affect and poor sleep suggest that immune-brain 
signaling tend to occur (or may be more readily detected) under contexts that necessitate 
homeostasis, highlighting the intricate and sophisticated relationship between the co-evolved 
brain and immune systems. If homeostasis is not achieved due to chronic stress or prolonged 
sleep restriction, increased allostatic load on these biological systems could lead to dysregulation 
and increased risk for psychological and physical health problems. Indeed, research suggests a 
robust relationship between immune dysregulation and depressive symptoms, which share many 
features with the repertoire of sickness behaviors (Brymer, Romay-Tallon, Allen, Caruncho, & 
Kalynchuk, 2019; Cho, Eisenberger, Olmstead, Breen, & Irwin, 2016; Dantzer, 2009; Medina-
Rodriguez, Lowell, Worthen, Syed, & Beurel, 2018; Slavich & Irwin, 2014). 
The findings from the current dissertation need to be interpreted in the context of the 
studies’ limitations. First, there may be limited generalizability of the current findings to younger 
and older adolescents, as the current sample only spanned 14-15 years of age. Additionally, self-
selection bias may have influenced the results given that immune data were only available from 
adolescents who opted in for the blood draw, who could differ from those who chose not to 
provide a blood sample for reasons unknown. Second, the correlational nature of the design 
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precludes drawing any conclusions regarding directionality of the findings. Third, immune 
markers measured in the periphery may not represent/reflect the inflammatory environment in 
the brain. Fourth, because of the relatively small sample size, other relevant biological and health 
factors (e.g., ethnicity, socioeconomic status, physical activity, diet, smoking/drinking behaviors, 
medical history) that could potentially confound the findings could not all be taken into account 
in analyses. Nevertheless, despite the small sample size, the strengths of the current study lie in 
the multi-method and multi-system data collected, including fMRI data, extensive questionnaire 
and daily diary measures, and venipuncture draws with multiplex immunoassay. The daily diary 
measures allow one to link real-world experiences to laboratory findings while the multiplex 
immunoassay extends the literature by examining other inflammatory markers beyond IL-6 and 
CRP. While these data collection methods may have limited the sample size due to a relatively 
high demand placed on participants’ time and energy, the richness of the collected data allowed 
novel research questions to be answered.  
Future studies that manipulate cytokine levels and relate them to affective and cognitive 
neurocircuitry longitudinally would provide further insight into the complex relationship 
between the immune system and neurodevelopment during adolescence. Another avenue for 
future research would be to determine whether certain features/patterns of immune-brain 
associations are unique to adolescence relative to other developmental periods. Answers to these 
questions would elucidate novel pathways for intervention to reduce the risk of psychiatric and 
physical problems during adolescence and across the lifespan.   
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